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Abstract 
A low-impact, high-intensity interval exercise (HIE) bout was used to determine whether 
an association exists between cytokines and bone turnover markers following an acute 
bout of exercise. Twenty-three recreationally active males (21.8±2.4yr) performed a 
single HIE bout on a cycle ergometer at 90% relative intensity. Venous blood samples 
were collected prior to exercise, 5-minutes, 1-hour, and 24-hours post-exercise, and were 
analyzed for serum levels of pro-inflammatory (IL-6, IL-1α, IL-1β, and TNF-α) and anti-
inflammatory cytokines (IL-10) and markers of bone formation (BAP, OPG) and 
resorption (NTX, RANKL). Significant effects were observed with all bone markers, 
especially 5-minutes post-exercise with BAP, OPG, and RANKL increasing from 
baseline (p<0.05). Significant effects were also observed for IL-1α, IL-1β, IL-6, and 
TNF-α (p<0.00, p=0.04, p=0.03, p<0.00). In addition, post-exercise changes in NTX, 
BAP, and OPG were significantly correlated pro- and anti-inflammatory cytokines, 
suggesting that an interaction exists between the immune and skeletal response to 
exercise.   
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Chapter 1: Literature Review 
 
1.1 Bone Cells 
Bone remodeling is a multicellular process. Bone resorption and bone formation are 
conducted through the communication of several cell types, however the two key cells 
that are responsible for these functions are the osteoclasts (bone resorption cells) and 
osteoblasts (bone formation cells). Both osteoclasts and osteoblasts undergo several 
morphological phases before they differentiate into their active resorption and formation 
phase. These cells originate from different precursors, perform different functions on 
bone tissue, and are activated by separate molecular pathways, yet they are well-
coordinated not only by local signals but also by each other to maintain the structure of 
bone (Kular et al., 2012). 
 
1.1.1 Osteoclast differentiation and proliferation 
Osteoclasts are large multinucleated cells formed by the fusion of mononuclear 
progenitor cells that originate from the monocyte family. The differentiation of 
osteoclasts, also known as osteoclastogenesis, is controlled by contact-mediated signaling 
between osteoblasts and osteoclasts (Blair et al., 2002). As seen in Figure 1, 
osteoclastogenesis is initiated when a hematopoetic stem cell from the bone marrow or 
spleen is stimulated to generate mononuclear cells (monocytes or macrophages), this 
stimulus arises from factors produced by marrow stromal cells, osteoblasts, or T-
lymphocytes (Kular et al., 2012; Robling et al., 2006). These mononuclear cells become 
committed preosteoclasts and are introduced into the blood stream (Figure 1). The 
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functional state in which the osteoclast precursors are found in the peripheral circulation 
before they reach their resorptive site is known as the motile phase. During this phase, 
motile osteoclasts are flattened and non-polarised cells. Morphologically, motile 
osteoclasts are characterized by membrane protrusions, called lamellipodia, and 
podosome complexes containing actin (Kular et al., 2012). The movement of the motile 
osteoclasts is facilitated by the lamellipodia formation.  
The end of the motile phase is marked when the osteoclasts exit the peripheral 
circulation at or near the site to be resorbed and fuse with one another to form a 
multinucleated immature osteoclast (Figure 1). This functional state in which the 
osteoclasts exert their bone resorbing function is known as the resorptive phase. At this 
phase, resorptive osteoclasts attach to the bone surface and subsequently undergo 
cytoskeletal reorganization, after which they become polarized (Kular et al., 2012). 
Polarization results into development of morphological changes and formation of 
domains. The lamellipodia developed in the non-motile state disappear and the 
osteoclasts develop a large dome-shape and ruffled border. The domains that are acquired 
during this state are the sealing zone, functional secretory domain and basolateral 
membrane. These domains are important for the resorptive function of the osteoclast, 
which begins as soon as the cells reach osteoclast maturity (Robling et al., 2006). Once 
peripherally attached to the matrix of the bone, the osteoclast engages in bone resorption 
by forming a tightly sealed compartment and pumping out H+ ions that cause 
extracellular acidification (Blair et al., 2002). This leads to calcium resorption as well as 
the digestion of collagen fragments such as amino-terminal cross-linking propeptide 
(NTx) and carboxy-terminal collagen cross-linking propeptide (CTx) (Banfi et al., 2012).  
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1.1.2 Osteoblast differentiation and proliferation 
Unlike osteoclasts, osteoblasts are derived from mesenchymal stem cells of the bone 
marrow and periosteum (Figure 1) (Datta et al., 2008). Mesenchymal stem cells require 
specific stimuli in order for them to differentiate into osteoblast precursors; otherwise 
they may also differentiate into adipocyte, myocytes, or chondrocytes (Robling et al., 
2006). In order for mesenchymal stem cells to differentiate into the osteoblast lineage, the 
expression of transcription factors, such as the runt-related transcription factor-2 (Runx2) 
is required (Robling et al., 2006).  
Similarly to osteoclasts, osteoblasts also have separate functional phases: the 
preosteoblast, mature osteoblast, bone lining cell, and osteocyte phases (Sims & Gooi, 
2008) (Figure 1). Upon the activation of the osteoblast transcription factors, the 
mesenchymal stem cells differentiate into committed preosteoblasts (Sims & Gooi, 
2008). Despite the fact that preosteoblasts lack the ability to produce mineralized tissue, 
these cells are very similar to mature osteoblasts in function and morphology. Like 
osteoblasts, preosteoblasts secrete type 1 collagen (PICP), which is the basic building 
block of bone, in addition to bone alkaline phosphatase (BAP), which is an essential 
enzyme for bone deposition (Robling et al., 2006). Preosteoblasts reside along the bone 
surface at sites of active bone formation until they differentiate into mature osteoblasts.  
Mature osteoblasts are cuboidal in shape, produce type 1 collagen and BAP, and 
also form bone. Bone formation is carried out by osteoblasts through the deposition of 
unmineralized matrix (Robling et al., 2006). The new bone is organized into multicellular 
units of osteoblasts connected by gap junctions, called osteons. Each osteon retains 
collagen strand orientation and the individual cells remain alive and interconnected 
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during the life of the functional bone unit. Osteoblasts that remain on the surface of bone 
are called bone-lining cells (Kular et al., 2012). These cells are quiescent and are 
important in initiating the formation of the remodelling compartment. By releasing a 
digestive enzyme called collagenase, bone lining cells digest unmineralized matrix in 
preparation for the underlying mineralized matrix to be resorbed by osteoclasts (Sims & 
Gooi, 2008). The alternative fate of osteoblasts, which is also final functional stage, is the 
differentiation into osteocytes. At one point the osteoblasts become completely engulfed 
by the matrix that they themselves synthesize and subsequently become osteocytes 
(Figure 1) (Datta et al., 2008).  
Osteocytes are terminally differentiated cells that are found dispersed throughout 
the matrix. Around 95% of the bone cells in the adult skeleton are osteocytes 
(Bloomfield, 2001). These cells have extensive cell processes that extend outwards via 
minute channels in the bone matrix called canaliculi, which connect with adjacent 
lacunae (Bloomfield, 2001). Although osteocytes seem inactive compared to osteoblasts 
and osteoclasts, they happen to play a very fundamental role in bone remodelling. 
Osteocytes use their dendritic cell processes to communicate with other osteocytes, 
osteoblasts, and osteoclasts via gap junctions. This elaborate network of communication 
allows osteocytes to partly regulate bone formation and bone resorption by producing 
chemokines that influence osteoblast and osteoclast activity (Sims & Gooi, 2008). In 
addition, recent research has shown that osteocytes also act as mechanosensory cells that 
are responsible for initiating the responses of osteoblasts and osteoclasts to mechanical 
loading (Datta et al., 2008).  
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1.2 Bone Signaling Pathways 
More current research has focused in determining the signaling pathways that modulate 
bone remodeling. The differentiation of osteoclasts and osteoblasts involves 
spatiotemporal coordination of interaction among diverse endocrine, paracrine, and 
autocrine factors (Datta et al., 2008). 
 
 
Figure 1 Differentiation of osteoblasts and osteoclasts: (A) The differentiation of 
mesenchymal cells into cells of the osteoblastic lineage is dependent on Runx2 and osterix 
expression. Mesenchymal cells differentiate into preosteoblasts via the Wnt signaling and 
BMP pathways. Towards osteoblast maturation, BMP is also critical for promoting 
osteoblastic bone formation. Eventually osteoblasts become engulfed by the matrix they 
produce, which stimulates their differentiation into osteocytes (B) Osteoclasts originate from 
cells of the monocyte and macrophage lineage. Monocytes and macrophages (which 
differentiate from hematopoietic stem cells) express the c-Fms receptor, which is the binding 
site for M-CSF. M-CSF signaling is crucial for the generation of preosteoblasts and also for 
the expression of RANK in monocytes and macrophages. The expression of RANK allows 
these cells to respond to RANKL (secreted by osteoblasts), which promotes 
osteoclastogenesis. RANKL is also responsible for stimulating osteoclast bone resorption.   
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1.2.1 Osteoclast signaling 
Osteoclast proliferation and differentiation is heavily reliant on the expression of the 
nuclear factor of activated T-cells c1 (NFATc1), which happens to be the master 
transcription factor of osteoclastogenesis (Shinohara & Takayanagi, 2007). Previous 
studies have shown that signaling cascades responsible for osteoclastogenesis eventually 
increase the expression of NFATc1, which attaches to its promoter site in the nucleus. 
The importance of NFATc1 in these signaling pathways has been demonstrated by 
studies in which NFATc1-deficient embryonic stem cells were not able to differentiate 
into osteoclasts (Shinohara & Takayanagi, 2007). Recently, it has been shown that 
NFATc1 is activated by multiple pathways. The two pathways that have been researched 
extensively are the macrophage colony-stimulating factor (M-CSF) and receptor activator 
of NF- κB (RANK) pathways, as presented in Figure 1 and Figure 2 (Shinohara & 
Takayanagi, 2007). 
 In the M-CSF signaling pathway, M-CSF binds to the plasma membrane of 
osteoclast precursor cells through a specific colony stimulating factor-1 receptor (c-Fms), 
which is a member of the tyrosine kinase superfamily (Shinohara & Takayanagi, 2007). 
c-Fms becomes autophosphorylated and attracts phosphatidylinositol 3-kinase (PI3K) and 
growth factor receptor bound protein-2 (Grb-2), which subsequently leads to the 
activation of Akt and mitogen activated protein kinase (MAPK). The activation of Akt 
and MAPK lead to the phosphorylation of the microphthalmia transcription factor 
(MITF), which translocates into the nucleus and forms a complex with NFATc1. This 
complex binds to its promoter site of osteoclast-specific genes that are critical for 
osteoclast differentiation and survival (Shinohara & Takayanagi, 2007). 
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Figure 2 Osteoclastogenesis signaling: Osteoclast proliferation and differentiation is 
reliant on the expression of NFATc1, which can be activated by (A) M-CSF and (B) 
RANKL and possibly other (C) unknown ligands (Shinohara & Takayanagi, 2007). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Osteoclast differentiation is also jointly regulated by the RANK ligand (RANKL) 
pathway (Figure 2). Briefly, RANKL (which is secreted by osteoblasts) binds to its type 1 
transmembrane receptor RANK, leading to the recruitment of TNF receptor associated 
factor-6 (TRAF6), which activates MAPK and inhibitor κB kinase (IKK). MAPK 
activates activator protein-1 (AP-1), which translocates into the nucleas and interacts with 
NFATc1 thereby further promoting the expression of osteoclast-specific genes. IKK also 
A B C 
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promotes osteoclast differentiation by activating another dimeric transcription factor 
complex NF-κB which in turn also translocates into the nucleus to stimulate 
osteoclastogenesis (Shinohara & Takayanagi, 2007). 
 
1.2.2 Osteoblast signaling 
The differentiation of osteoblasts has been elucidated in previous studies to be mediated 
by the expression of Runx2 and Osterix, which are key osteoblast differentiation 
transcription factors (Datta et al., 2008). The importance of Runx2 and Osterix expression 
in bone development has been demonstrated in earlier studies using Osterix -/- and Runx2 
-/- mice that showed similar resulting phenotypes; both mice presented a lack of 
endochondral and intramembraneous ossification due to the absence of osteoblast 
differentiation (Datta et al., 2008). Runx2 acts on mesenchymal stem cells by promoting 
their differentiation into cells of the osteoblastic lineage and also by inhibiting the 
differentiation of mesenchymal stem cells into adipocytes and chondrocytes. Osterix is 
believed to act downstream of Runx2 in promoting osteoblast differentiation. The 
expression of both Runx2 and Osterix is activated by two main factors: Wingless tail 
ligands (Wnts) and bone morphogenic proteins (BMPs).  Both factors activate signaling  
pathways that jointly promote Runx2 and Osterix expression thereby promoting 
osteoblast proliferation and differentiation, as seen in Figure 1 and Figure 3 (Toulis et al., 
2011). 
 Wnt ligands are lipid-modified, cysteine-rich glycoproteins that play an important 
role in osteoblast proliferation and differentiation (Toulis et al., 2011). These proteins 
activate three distinct intracellular signaling pathways, including the Wnt/catenin-β 
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pathway, also known as the canonical Wnt pathway (Figure 2). This pathway is initiated 
when Wnt ligands interact with a member of the Frizzled family (Fzd) and the co-
receptor lipoprotein-receptor related protein (LRP) 5 or 6 on the osteoprogenitor cells. 
This interaction leads to the formation of a receptor complex (Wnt-Fzd and LRP5/6), 
which inhibits the phosphorylation of β-catenin by glycogen synthase kinase-3β (GSK3). 
In the absence of Wnt ligands, β-catenin is phosphorylated by GSK3, which promotes the 
ubiquitination and proteosomal degradation of β-catenin (Datta et al., 2008). However, in 
the presence of Wnt ligands, the degradation of β-catenin is inhibited thereby resulting in 
its accumulation in the cytoplasm and its translocation into the nucleus. Upon entering 
the nucleus, β-catenin binds to T cell-specific transcription factor/lymphoid enhancer-
binding factor 1 (TCF/LEF) transcription factors and activates the transcription of 
downstream genes including Runx2 (Toulis et al., 2011).  In addition to having 
receptors for Wnt ligands, osteoprogenitor cells and osteoblasts have receptors for BMPs 
(Figure 3). BMPs are members of the transforming growth factor- β (TGF-β) family that 
have osteoinductive properties (Datta et al., 2008). There are various forms of BMPs not 
all of which are limited to bone. The main BMPs that act on osteoblasts are BMP-2, 
BMP-4, and BMP-6. BMPs act on osteoprogenitor cells by binding to two receptors that 
have intrinsic serine/threonine kinase activity: activin receptor type I (ActR1) and activin 
receptor type II (ActR2) (not shown in Figure 3) (Toulis et al. 2011). The ligand binds to 
the assembly of a heterooligomeric receptor complex, in which the ActR2 phosphorylates  
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Figure 3 Osteoblastogenesis signaling: A. Canonical Wnt pathway. The binding of Wnt to LRP (in 
the active state) leads to downstream events that result into the activation of osteoblast transcription 
factors such as Runx2 and Osterix. B. BMP pathway. BMP binds to ActR (also known as BMPR) 
promote the expression of osteogenic genes through mitogen-activated protein kinase (MAPK) 
activation (Yavropoulou & Yovos, 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and activates the ActR1. ActR1 in turn phosphorylates a family of receptor substrates, 
known as the Smad proteins (Smad-1, Smad-5, and Smad-8), which in turn dissociate and 
form a complex with Smad-4. The Smad complex migrates into the nucleus where it 
drives gene transcription of osteogenic genes (Zhang et al., 2009). In addition to Smad 
activation, BMPs can promote the expression of osteogenic genes through mitogen-
activated protein kinase (MAPK) activation (Kular et al., 2012). 
 
 
 
  A 
 
 
  B 
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1.3 Communication between Osteoclasts and Osteoblasts 
Throughout this section, the activities and signaling pathways of osteoclasts and 
osteoblasts have been discussed as independent mechanisms. However, it is important to 
note that the activities of these cells in an in vivo setting, and sometimes in vitro, are far 
from independent (Sims & Gooi, 2008). Osteoclasts and osteoblasts are closely coupled 
and there exists a great amount of overlap between the signaling pathways and biological 
markers that stimulate their activities.  
One such example of their coupled coordination is the production of 
osteoprotegerin (OPG) by osteoblasts, which is the decoy receptor of RANK (Sims & 
Gooi, 2008). OPG acts an inhibitor of the RANK pathway by binding to RANKL, which 
prevents RANKL from attaching to designated osteoclast receptors. This mechanism 
allows osteoblasts to regulate osteoclast resorption to prevent an excessive loss of bone 
matrix. Simultaneously, osteoblasts can also express RANKL and M-CSF to stimulate 
osteoclastogenesis when needed (Sims & Gooi, 2008). Osteoblasts also secrete 
chemoattractants such as osteocalcin (OC) and collagen-1 that control the movement of 
osteoclast precursors to the bone surface (Kular et al., 2012). Other cells of the 
osteoblast-lineage may also influence osteoclast activity, such as osteocytes. Osteocyte 
apoptosis has been postulated to release prostaglandins and cytokines that initiate bone 
resorption, thereby confirming a physiological link between osteocytes and osteoclasts 
(Sims & Gooi, 2008). 
Osteoclasts also regulate osteoblasts activity, though not the same extent as 
osteoblasts. Osteoclasts regulate osteoblast activity by secreting ligands that influence 
pathways responsible for osteoblast proliferation and differentiation. An example of 
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osteoclastic modulation occurs during bone resorption, in which osteoclasts secrete 
factors into the matrix that stimulate bone formation by osteoblasts. These regulatory 
factors include insulin-like growth factor (IGF) 1 and 2, acidic and basic fibroblast 
growth factor (FGF), TGF-β 1, BMPs, and platelet-derived growth factor (PDGF) (Sims 
& Gooi, 2008). The concentrations of these regulatory factors in the bone matrix 
correlates with osteoclast activity, thus this will promote bone formation that is 
proportional to bone resorption (Sims & Gooi, 2008). 
 The coupled activities of osteoclasts and osteoblasts are very crucial to bone 
structure, strength, and homeostasis (Datta et al., 2008). In addition to bone maintenance, 
osteoclasts and osteoblasts communicate with one another and other factors during bone 
healing that may occur after fracture or disease. An imbalance between either cell 
population may lead to the development of bone degenerative conditions such as 
osteoporosis, osteopenia, and other bone metabolism disorders. Thus successful activity 
of osteoblasts and osteoclasts is dependent on the proper transmission of signals and 
equipment of messengers that regulate their activities in a harmonious nature. Of great 
importance to osteoblast and osteoclast regulation are cytokines.  
 
1.4 Cytokines 
Cytokines are soluble mediators that regulate the interaction and communication between 
cells. They are small to medium sized proteins or glycoproteins with molecular weights 
ranging from 8 to 40,000 Da. Cytokines play central roles in the immune response, 
hematopoiesis, and inflammation, which are very well established in the literature 
(Takayanagi, 2007). Cytokine is the general term, however cytokines can also be termed 
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according to their activity or cellular source. Other names include chemokines (cytokines 
with chemotactic activities), lymphokines (cytokines secreted by lymphocytes), 
monokines (cytokines secreted by monocytes), adipokines (cytokines secreted by 
adipocytes), myokines (cytokines secreted by myoblasts), and interleukins (cytokines 
secreted by leukocytes) (Pederson, 2011; You & Nicklas, 2008; Zhang & An, 2007). 
 Cytokines may exhibit functions that are autocrine (acting on the same cells that 
secrete them), paracrine (acting on nearby cells) or endocrine (acting on distant cells) 
(Zhang & An, 2007). Originally, cytokines were thought to be specific in function (Akira 
et al., 1990). However, research with a variety of cell types has demonstrated that 
cytokines are able to mediate a vast array of different biological functions. In fact, most 
cytokines are distinguished by their multifunctionality, or pleiotropy. One cytokine may 
produce a variety of actions depending on the source of its secretion, target tissue, and 
sequence of secretion in an event (Dinarello, 1998). Simultaneously, there is large extent 
of redundancy with cytokines as many of their functions overlap with one another. 
Numerous cytokines share the same target cell and mediate the same or similar processes 
(Akira et al., 1990).    
 
1.4.1 Cytokines and inflammation 
Cytokines are mainly only produced during noxious events, such as inflammation. 
Inflammation is a nonspecific reaction of the immune system that is required for 
functional host defense mechanisms, and can be triggered by various cell stressors such 
as microbial infection, disease, injury, and trauma (Dinarello, 1997).  This complex 
process involves host cells, blood vessels, and other proteins in order eliminate the source 
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of inflammation (Kumar et al., 2012). Furthermore inflammation can be acute, lasting 
from a few minutes to a few days, or chronic, from days to possibly years. Generally, 
inflammation is characterized by the recruitment of leukocytes and plasma proteins to the 
site of injury or infection. Both leukocytes and plasma proteins, such as clotting factors 
and kininogens, assist with the elimination of microbes and dead tissue and mediate 
inflammation. In addition to these factors, endothelial cells within the vascular walls and 
cells of the extracellular matrix (ECM) also assist in the induction of inflammation and 
the resolution (Kumar et al., 2012). Endothelial cells may aggravate the onset of 
inflammation by releasing inflammatory mediators such as nitric oxide, prostaglandin, 
and histamine. Other cell types such as fibroblasts, dendritic cells, mast cells and 
macrophages can also synthesize inflammatory mediators. In addition, these cells also 
secrete cytokines, which are crucial for inflammatory processes.  
There are two classifications for cytokines with respect to inflammation: pro-
inflammatory cytokines and anti-inflammatory cytokines. The concept of this 
classification is based on cytokine induced synthesis of mediator molecules that are up 
regulated during inflammation (Dinarello, 2000). Pro-inflammatory cytokines up-regulate 
mediators that aggravate inflammation, such as adhesion molecules, nitric oxide, 
prostanglandin, and platelet activating factors (Dinarello, 2000). Anti-inflammatory 
cytokines attenuate inflammation by controlling the inflammatory response and 
stimulating inhibitors of inflammatory pathways (Dinarello, 2000). Of importance to this 
paper are the activities and signaling pathways of the anti-inflammatory cytokine 
interleukin 10 (IL-10), and four pro-inflammatory cytokines: interleukin 1 alpha (IL-1), 
interleukin beta (IL-1β), tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6). 
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The selection of these cytokines is based on the established literature that mainly focuses 
on the levels of IL-10, IL-1α, IL-1β, TNF-α and interleukin IL-6 in association to acute 
bouts of exercise.  
 
1.4.2 Interleukin-1  
IL-1 is a family of highly inflammatory cytokines that includes the peptides IL-1α and 
IL-1β. They are two distinct proteins with varying degrees of inflammatory effects. IL-1
α consists of 271 amino acids and has a molecular weight of 31 kDa (Akira et al., 1990; 
Dinarello, 1991). The main producers of IL-1α  are monocytes and macrophages, 
however it can also be produced by keratinocytes, endothelial cells, T cells, B cells, 
astrocytes, microglia and fibroblasts (Akira et al., 1990). IL-1α is first synthesized in a 
precursor form known as proIL-1α, and is subsequently converted into its active form by 
cleavage of an intracellular protease calcium dependent cysteine protease, known as 
caspase, or by the influx of calcium into the cell (Gross et al., 2012; Miller et al., 1994). 
The active form of IL-1α is bound to nuclear DNA, where it is released upon cell death 
to bind to a membrane bound receptor on nearby cells (Luheshi et al., 2011; Rider et al., 
2011). The binding of IL-1α  upon necrotic cell death triggers a pro-inflammatory 
response that is characterized by a neutrophilic influx, followed by an influx of 
monocytes (Rider et al., 2011). IL-1α also induces the transcription of phospholipase A2 
and cyclooxygenase, which are genes that up regulate the synthesis of inflammatory 
leukotrienes and prostanglandins (Dinarello, 1997). 
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 IL-1β has similar action to IL-1α, including the up regulation of chemokines 
and other inflammatory cytokines such as IL-6 and TNF-α (Dinarello, 2011). IL-1β is 
269 amino acids long and has a molecular weight of 31 kDa (Akira et al., 1990). 
Similarly to IL-1α, it is produced by monocytes, macrophages, and dendritic cells, as 
well as B lymphocytes and natural killer cells (van de Veerdonk & Netea, 2013). The 
inactive form of IL-1β, which is proIL-1β, is also processed by caspase; however it can 
also be converted into the active form by acute phase proteins such as proteinase-3 (van 
de Veerdonk & Netea, 2013). Following the synthesis of the active cytokine in the 
cytoplasm, IL-1β is transported by exocytosis and enters the circulation where it acts on 
target cells such as fibroblasts, endothelial cells, and keratinocytes (Tosato & Jones, 
1990). 
 
1.4.3 Tumor Necrosis Factor Alpha 
TNF-α, also known as cachectin, is a highly inflammatory cytokine that is involved in 
both systemic and local inflammation. It was first named TNF-α for its ability to destroy 
tumors by obliterating their vessels or by direct attack on the cells (Zhang & An, 2007). It 
is expressed ubiquitously in tissue, which may explain why its pro-inflammatory effects 
are very prominent compared to other cytokines (Northoff & Berg, 1991). TNF-α is 
released by a variety of cells, including activated keratinocytes, dendrocytes, monocytes, 
macrophages, mast cells and activated B and T cells (Weinberg et al. 2006). It exists in 
both soluble and membrane bound form, with molecular weights of 17 kDa and 26 kDa 
(Weinberg et al., 2006).  There are two receptors for TNF-α, p55 and p75, both of which 
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are similar to some extent. The binding of TNF-α to p55 and p75, which can exist as 
membrane bound receptors or in soluble form in extracellular fluid, leads to increased 
expression of other cytokines and cell adhesion molecules, and the emigration of 
lymphocyte and neutrophils (Dinarello, 1997; Opal & DePalo, 2000). The difference 
between the two receptors is that p55 stimulates the cell to undergo apoptosis, while p75 
does not (Opal & DePalo, 2000). Similarly to the IL-1 family, TNF-α up regulates the 
expression of carbon dioxide and nitric oxide synthase inhibitors. In fact, IL-1 and TNF-
α overlap in many of their functions that they are considered to be synergistic cytokines.  
 
1.4.4 Interleukin-6 
IL-6 is an extensively studied cytokine that is associated with a wide range of functions. 
It is a single glycoprotein chain of 26 kDa and consists of 212 amino acids (Barton, 
1997). IL-6 can be produced by monocytes, macrophages, fibroblasts, endothelial cells, 
and B cells (Barton, 1997) IL-6 is also considered a myokine as it can be produced by 
skeletal muscle as well (Pedersen, 2011).  The receptor for IL-6 is a membrane bound 
heterodimer consisting of an alpha and beta subunit. The beta subunit, also known as 
gp130, is responsible for signal transduction. IL-6 receptors are expressed a variety of 
cells, including lymphocytes, monocytes, fibroblasts, endothelial cells, and pituitary cells 
(Barton, 1997). 
Findings regarding the role of IL-6 during inflammation are interesting as it can 
exhibit both pro-inflammatory and anti-inflammatory actions (Akira et al., 1990). In the 
case of chronic inflammation, such as arthritis, colitis and autoimmune disease, IL-6 is 
pro-inflammatory and also a key player in mediating the pro-inflammatory response. 
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Upon persistent inflammation, IL-6 induces neutrophilic apoptosis and phagocytosis, and 
up regulates the expression of adhesion molecules and other pro-inflammatory cytokines 
such as IL-8. The main function of IL-6 during chronic inflammation is the recruitment of 
monocytes to the area of injury or inflammation, which leads to the continuous 
production of the proinflammatory monocyte chemoattractant protein (MIP)-1 (Gleeson 
et al., 2011). Thus IL-6 levels are elevated in inflammatory disease in humans. In 
addition, IL-6 may also be secreted by damaged tissue, as seen with muscle very 
strenuous exercise (Pederson, 2011).   
 Simultaneously, IL-6 also exhibits anti-inflammatory effects indirectly during 
acute inflammation as seen with injury, infection or trauma. The anti-inflammatory 
actions of IL-6 in this case are mostly focused towards inhibiting the production of pro-
inflammatory cytokines such as interferon gamma (IFN-γ ), IL-8, and MIP-2. In 
addition, it also inhibits the synthesis of other major inflammatory mediators such as 
prostaglandins, nitric oxide, and phospholipase (LPS2) as well as inflammatory processes 
such as apoptosis and the recruitment of monocytes and adhesion molecules to the site of 
injury (Barton, 1997). At the same time, IL-6 also down-regulates the synthesis of IL-1 
and TNF-α  in a negative feedback fashion, thereby attenuating their inflammatory 
effects (Opal & DePalo, 2000).  
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1.4.5 Interleukin-10 
Perhaps the most studied anti-inflammatory cytokine is IL-10 (Opal & DePalo, 2000). It 
is a homodimer of 18.5 kDa consisting of 160 amino acids (Opal & DePalo, 2000). It is 
produced by T helper cells, lymphocytes, mast cells, eosinophils, monocytes, 
macrophages and keratinocytes (Lalani et al., 1997). The receptor for IL-10 is a 
membrane bound receptor of 90-110 kDa. The binding of IL-10 to its receptor inhibits the 
expression monocyte and macrophage derived pro-inflammatory cytokines such as TNF- 
α, IL-1, IL-6, IL-8 and IL-12 as well as other pro-inflammatory mediators such as the 
macrophage and granulocyte colony stimulating factor (Opal & DePalo, 2000). It also 
prevents the synthesis of pro-inflammatory cytokines by natural killer cells and 
neutrophils and promotes the degradation of messenger mRNA of pro-inflammatory 
cytokines (Opal & DePalo, 2000). Furthermore, IL-10 inhibits the recruitment of 
monocytes and leukocytes to the site of inflammation and down regulates the production 
of nitric oxide and prostaglandins, thereby attenuating tissue damage caused by 
inflammation. IL-10 also reduces the pro-inflammatory response by regulating the 
production of pro-inflammatory cytokine receptors. For example, IL-10 attenuates the 
expression of TNF-α  receptors and promotes the shedding of TNF receptors into 
systemic circulation, and promotes the production of IL-1 receptor antagonist, ultimately 
minimizing the pro-inflammatory responses of TNF-α and IL-1. (Lalani et al., 1997; 
Opal & DePalo, 2000).  
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1.5 Cytokine Signal Transduction 
Over the past decade a number of proteins have been identified that are necessary for the 
signaling of pro-inflammatory and ant-inflammatory cytokines. With respect to the 
cytokines discussed in this paper, two signaling pathways are relevant, the NF-κB 
pathway, which is activated by IL-1-α , IL-1β , and TNF-α , and the JAK/STAT 
pathway, which is activated by IL-6 and IL-10. Both signaling pathways are presented in 
Figure 4. 
 
1.5.1 NF-κB 
NF-κB is a transcription factor that is usually contained in the cytoplasm of most cells 
through the interaction with inhibitory NF-κB proteins (IκB). The activation of NF-κB 
is a crucial step in the development of inflammation and it can be initiated by pro-
inflammatory cytokines, such as IL-1 or TNF-α. These cytokines activate their distinct 
receptors, which subsequently lead to the activation IKK via phosphorylation (Delhase et 
al., 1999; Hanada & Yoshimura, 2002) (Figure 4). The activation of IKK leads to the 
phosphorylation of IκB at serine residues, which leads to its degradation by 26S 
proteasome, thereby releasing NF-κB dimers from the cytoplasmic NF-κ b-IKB 
complex, allowing them to translocate into the nucleus where they activate transcription 
of target genes that encode for additional pro-inflammatory cytokines, including IL-1α, 
IL-β and TNF-α (Baldwin, 1996). This mechanism also regulates the production of 
adhesion molecules, chemokines, growth factors, and inducible enzymes 
cyclooxygenase-2 and nitric oxide synthase. 
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1.5.2 JAK/STAT 
Other cytokines, including IL-6 and IL-10, regulate inflammation through the JAK/STAT 
pathway (Figure 4). When a cytokine binds to the distinct receptors, the subunits of the 
receptor homodimerizes, which results the activation of intracellular tyrosine kinase 
named JAK kinase (Hanada & Yoshimura, 2002). The receptor is then phosphorylated by 
JAK kinase; this creates docking sites for SH2-containing signaling molecules, amongst 
them are signal transducers and activators of transcription (STAT) (Figure 4).  STAT is a 
transcription factor usually contained within the cytoplasm in monomeric inactive forms 
(O’Farrell et al., 1998). STAT is phosphorylated by JAK, which triggers its dimerization 
and translocation into the nucleus (O'Farrell et al., 1998). Upon entering the nucleus, 
STAT promotes the transcription of target genes that regulate inflammation. Along with 
inflammatory regulators, the JAK/STAT pathway also increases the transcription of 
suppressors of cytokine signaling (SOCS) proteins, which thereby act as negative 
feedback regulators. 
 Interestingly the JAK/STAT pathway has been found to either promote or inhibit 
inflammation, specifically with the STAT3 protein (O'Farrell et al., 1998). When 
activated by IL-6 during chronic inflammation, STAT3 promotes inflammation by 
hyperplasia of epithelial cells and the survival of T cells and also enhances the production 
of other pro-inflammatory cytokines (Hanada & Yoshimura, 2002). However when 
stimulated by IL-10, it has been shown to provide anti-inflammatory effects via the 
inhibition of macrophage activation and proliferation (O'Farrell et al., 1998). 
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Figure 4 Cytokine signaling: NF-κB and JAK/STAT pathways. These pathways are important 
in regulating pro-inflammatory and anti-inflammatory processes. (A) NF-κB is activated by IL-
1-α, IL-1β, while the (B) JAK/STAT pathway is activated by IL-6 and IL-10 (Hanada & 
Yoshimura, 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.6 Interaction between bone and cytokines 
Until the 1970s, the skeletal system and immune system were always viewed as separate 
entities, with no means of interaction aside from the spatial proximity that exists between 
immune cells residing in the bone marrow (Schett, 2011). However, clinical research in 
arthritis patients in which pro-inflammatory cytokines are correlated with increased bone 
resorption showed that there is association between bone and cytokines (Korczowska et 
al., 2013). This has lead to the establishment of a new discipline that examines the 
interactions between the skeletal and immune systems, known as osteoimmunology 
(Takayanagi, 2012). 
 
  A 
 
 
  B 
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 Research in osteoimmunology examines the association between cytokines and 
bone cells. The first relationship that was established between these two systems lies in 
the bone marrow (Takayanagi, 2012). Hematopoietic stem cells, which reside in the bone 
marrow, give rise to both myeloid progenitors that differentiate into osteoclasts and 
lymphoid progenitors that give rise to immune cells that produce cytokines, such as T 
cells and macrophages (Danks & Takayanagi, 2013). Thus, bone regulates the 
development of cytokine progenitor cells by providing the niche for hematopoietic cell 
development. 
 Most of the interaction between bone and cytokines stems from cytokine 
regulation of bone cell activities. This interaction was originally linked to inflammatory 
diseases that involve bone such as arthritis, osteoporosis, and osteopenia, in which the 
degree of inflammation is proportional to bone loss, bone turnover, and the development 
of progressive bone erosions (Lee et al., 2008; Schett, 2011). These inflammatory 
diseases are characterized by an increase of circulating IL-1, IL-6 and TNF-α, all of 
which have been shown to promote bone resorption mainly by up-regulating the 
expression of RANKL, which is biomarker of osteoclastogenesis (Takayanagi, 2012). All 
three cytokines up-regulate the production of RANKL from mesenchymal cells, T cells, 
fibroblasts, and osteoblasts which act on osteoclast precursor cells to promote 
osteoclastogenesis and bone resorption (Schett, 2011; Takayanagi, 2012). These 
cytokines can also promote osteoclastogenesis independently of RANKL; TNF-α 
promotes osteoclast formation by up-regulating the expression of M-CSF and OSCAR on 
osteoclast precursors (Both M-CSF and OSCAR pathways are illustrated in Figure 2), IL-
1 increases prostanglandin synthesis in bone, which stimulates resorptive activity, and IL-
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6 promotes the differentiation of myloid cells into osteoclasts (Kudo et al., 2003; Lee et 
al., 2008; Schett, 2011). Interestingly IL-6 can produce variable effects on 
osteoclastogenesis depending on whether it is bound to a soluble receptor complex (IL-
6/R). The main action of IL-6 on osteoclastogenesis has been shown to occur in the form 
of IL-6/R, which promotes osteoclastogenesis and RANKL production. Although IL-6 
mainly promotes bone resorption, it can also bind directly on mesenchymal cells to 
stimulate osteoblast differentiation (Steeve et al. 2004; Schett 2011). On the contrary, 
pro-inflammatory cytokines such as TNF-α have also been shown to inhibit osteoblast 
activity and induce osteoblast apoptosis (Walsh et al., 2006). The effects of pro-
inflammatory cytokines on bone have also been examined in animal studies in which 
molecules necessary for cytokine signaling transduction such as IκB and NF-κb have 
been genetically disrupted. In mice, the elimination of IKKB and NF-κB, both of which 
are regulatory molecules for IL-1 and TNF-α signaling, resulted in decreased osteoclast 
differentiation and bone resorption (Takayanagi, 2007). In summary, these studies show 
that pro-inflammatory cytokines have the capacity to modulate bone physiology through 
various mechanisms, mainly through promoting osteoclastogenesis.  
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Figure 5 Interaction between bone and cytokines: The effects of IL-1, IL-6, TNF-α and IL-10 
have been shown to be targeted on osteoblasts, osteoclasts, and their precursors. The net effect of 
IL-1, TNF-α, and IL-6 is osteoclastogenesis, in which the predominant mechanism is 
RANK/RANKL pathway. These cytokines may also stimulate other factors, such as M-CSF and 
PGE2 in order to promote osteoclast differentiation. Although IL-6 can promote osteoblast 
differentiation directly, it mainly promotes osteoclastogenesis after binding to a soluble receptor 
and forming IL-6R. At early stages of osteoblast differentiation, IL-10 inhibits osteoblastogenesis 
while simultaneously inhibiting and enhancing RANKL and OPG production respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
In addition to pro-inflammatory cytokines, IL-10 has also been shown to 
influence bone physiology by regulating osteoclast activities. Using bone marrow 
cultures, IL-10 has been shown to inhibit osteoclastogenesis and bone resorption (Hong et 
al., 2000; Lee et al., 2008). IL-10 regulates osteoblastic regulation of osteoclasts by 
inhibiting and enhancing the production of RANKL and OPG respectively in 
preosteoblasts (Lee et al., 2008). IL-10 has no effects on the activities of mature 
osteoblasts, however it can modulate bone formation in the preosteoblastic stages in 
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which IL-10 inhibits BAP synthesis (Vlaesslear et al., 1994). Although IL-10 has not 
been shown to promote osteoblast differentiation or bone formation, the beneficial effects 
this anti-inflammatory cytokine has on bone come from its ability to reduce bone 
resorption and lower pro-inflammatory cytokines which promote resorptive activity 
(Caeteno-Lopes et al., 2009; Hong et al., 2000).  
 
1.7 Exercise 
Many complex interactions exist between the bone and immune system. Bone cells and 
cytokines are very dynamic and responsive to multiple factors. Some factors that regulate 
bone metabolism and cytokine levels are endogenous factors, such as hormones and   
protein factors, and others are exogenous factors such as nutrition, disease, injury, and 
exercise. It is very well established that exercise is an important regulator of bone 
turnover and inflammation (Banfi et al., 2012).  Studies conducted in humans, animals, 
and cell cultures have shown the effects of exercise and mechanical stimulation on bone 
health and inflammatory status. 
 
1.7.1 Exercise and bone 
Exercise is a very important behavior that influences bone health. Through exercise, peak 
bone mass is increased during childhood and the rate of bone loss is decreased in the 
elderly (Maimoun & Sultan, 2011). It is also a preventative measure against osteoporosis. 
Overall, studies assessing the effects of exercise on bone health have reported improved 
bone mineral density (BMD), bone strength, and a lower risk of fracture (Maimoun & 
Sultan, 2011). 
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 Some forms of exercise may cause more profound effects on bone than others. 
This is due to several factors that are manifested in the form of exercise, such as the 
mechanical load of the exercise (ie. high impact or low impact), intensity (high intensity 
or low intensity), and duration of exercise. High impact exercise, such as weight bearing 
and plyometric exercises, lead to an increase in BMD at sites affected by strains and 
provide more osteogenic effects (Guillemant et al., 2004; Maimoun et al., 2006). On the 
other hand, endurance and low-impact exercises have been shown to have no beneficial 
or even deleterious effects on bone density (Guillemant et al., 2004). In fact, no gain in 
BMD has been demonstrated in athletes (ie. cyclists) in the absence of high mechanical 
strain (Maimoun et al., 2006). However, this is not to say that low-impact exercise, such 
as cycling, does not have any beneficial effects on bone. In addition to bone quantity 
(BMD), another equally important determinant of bone strength is bone quality, which 
reflects the structure of bone (ie. trabecular spacing, trabecular number). No previous 
studies have assessed the effects of cycling or other forms of low-impact exercise on 
bone quality, therefore it remains inconclusive whether cycling has an effect on bone 
health. However, it is very unlikely that cycling does not stimulate bone turnover since it 
is generally known to stimulate systemic changes, such as endocrine (Pederson & 
Hoffman-Goetz, 2000) and immune (Pederson & Hoffman-Goetz, 2000), which in 
combination with a small degree of mechanical strain, may lead to beneficial outcomes 
on bone.   
 Many studies that assess the effects of exercise on bone health utilize imaging 
techniques such as dual-energy X-ray absorptiometry (DEXA) (Maimoun et al., 2006). 
Although this is the gold standard assessment for determining BMD, it is also 
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disadvantageous as it poses radiation risk to the individual and lacks a sensitive measure 
for the short-term effects of exercise on bone (Banfi et al., 2012). Thus, a more practical 
method of assessing bone health has emerged by utilizing biochemical factors such as 
bone formation and resorption markers (Banfi et al., 2012). These markers provide 
evidence of bone turnover and also a prediction of the cellular activities of osteoblasts 
and osteoclasts in bone formation and resorption. Table 1 lists common markers of bone 
formation and resorption that can be measured in urine or serum.  
Table 2 presents numerous studies that have utilized biochemical assays to 
understand the acute effects of exercise on bone with a focus on low-impact exercise. 
Most of these studies have used cycling as a form of low-impact exercise due to minimal  
 weight bearing and strain involved, however brisk walking has been used as well (Tosun 
Marker  Biological Material  
Bone Formation  
BAP Serum 
OC Serum 
PICP Serum 
PINP Serum 
OPG Serum 
 
Bone Resorption 
 
Pyr Urine or serum 
Dpd Urine or serum 
ICTP Serum 
  
Ntx Urine 
TRAP5b  Serum 
RANKL Serum 
BAP=bone alkaline phosphatase; CTx=carboxyterminal cross-linking telopeptide of type I 
collagen; NTx= aminoterminal cross-linking telopeptide of type I collagen; 
Dpd=deoxypiridinoline; ICTP=carboxyterminal cross-linked telopeptide of type I procollagen; 
NTx= aminoterminal cross-linking telopeptide of type I collagen; PICP = carboxyterminal 
propeptide of type I procollagen; PINP = aminoterminal propeptide of type I procollagen; 
Pyr=pyridinoline; OC=osteocalcin; TRAP5b=tartrate-resistant acid phosphatase (isoenzyme 
5b); RANKL= receptor activator of NF-kB ligand; OPG= osteoprotegerin 
Table 1: Bone turnover markers of formation and resorption  
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et al., 2006). The literature pertaining to the response of bone markers to high-intensity,   
low-impact exercise is discrepant, with some studies reporting an exercise-induced 
response in bone markers and others showing no significant changes (Tosun et al., 2006). 
Guillemant et al. (2004) and Hermann et al. (2007) reported significant increases in CTX 
(bone resorption marker) shortly after cycling at an intensity of at least 75% VO2max for 
at least 50 minutes. CTX returned to baseline 24 hours post-exercise. Similarly, ICTP 
(bone resorption marker) was shown to increase 30 minutes after cycling at 80% of 
VO2max, thereby implying an increase of bone resorption. Guillement et al. (2004) also 
measured BAP (bone formation marker) but found no significant change after exercise. 
However, Maimoun et al. (2006) and Rudberg et al. (2006) reported an increase in BAP 
immediately post-exercise, as well as 30 minutes post-exercise. Furthermore, other 
markers of bone formation such as OC and PICP have been shown to increase 
immediately and up to one hour post-exercise (Rudberg et al., 2000; Tosun et al., 2006; 
Wallace et al., 2000). All of these markers seem to return to pre-exercise levels 1 to 24 
hours after exercise. Taken together, the increase of bone resorption and bone formation 
markers after exercise indicates that high-intensity and low-impact exercise stimulates 
bone turnover that ceases a few hours after the exercise.  
 Other studies, however, reported no significant changes in bone marker after 
exercise (Kristoffersson et al. 1995; Tosun et al. 2006) including OC, PICP, ICTP and 
PINP. However, Kristofferson et al. 1995 utilized an exercise protocol lasting 30 sec 
while the studies described earlier adhered to at least 20 minutes of exercise. Therefore, it  
is possible that duration is an important factor governing the bone marker response to 
exercise (Maimoun et al., 2006). In addition, Tosun et al. (2006) investigated the effects 
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of low-impact exercise in healthy, pre-menopausal women, which indicates that sex may 
also be a factor in the bone response to exercise. 
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Table 2: Studies on the effects of acute and low-impact exercise on bone markers. 
 
Publication Exercise Mode Participants Method Outcome Measures Results 
Kristoffersson et al. 
1994  
CY; 30 sec at 7.5% 
retardation of body 
weight 
Male athletes,  
19-26 y 
N=7 
Serum OC, PICP, ICTP No significant changes during 
are post-exercise 
 
 
 
Rong et al. 1997 CY; Two sessions of 
acute exercise bouts: 45 
min at 55% VO2max and 
15 min at 85% VO2max 
Healthy males,  
20-26 y 
N=8 
Serum OC, ICTP No significant difference in  
 
OC and ICTP immediately or 
1h post-exercise 
ICTP decreased 4 h post-
exercise at both intensities 
OC decreased post-exercise at 
85% VO2max 
A positive correlation was 
found between OC and ICTP 
at all time points  
 
Wallace et al. 1999 CY; two 5-min sessions 
at 1 watt/kg, 2 watt/kg 
followed by session of 
20-min at 80% VO2max 
Males with a high 
level of habitual 
aerobic activity,  
18-40 y 
N=17 
Serum OC, PICP, PIIIP, ICTP PICP, PIIIP and ICTP 
increased 30 min post-exercise 
All markers decreased to 
baseline levels during recovery 
 
  
Rudberg et al. 1999 CY; 24 min at a 
workload of 120-180 W 
Healthy 
postmenopausal 
women, 53-61 y 
N=8 
Serum BAP BAP increased significantly 
immediately post-exercise, and 
returned to baseline 20 min 
post-exercise 
 
 
Guillemant et al. 
2004 
CY; 60-min at 80% 
VO2max 
Elite male 
triathletes, 23-37 y 
N=12 
Serum BAP, CTX CTX increased 30 min post-
exercise, and began to 
decrease 2 h post-exercise 
No significant changes were 
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observed with BAP  
 
Maimoun et al. 
2006 
CY; two 50-min sessions 
at 15% above (+VT) and 
below (-VT) 
Male cyclists,  
20-39 y, N=7 
Serum BAP, CTX, OC OC increased 30 and 50 min 
post-exercise at +VT 
BAP increased for both 
intensity levels 30 min post-
exercise 
CTX increased 30 and 50 min 
post-exercise at +VT  
All markers returned to 
baseline levels during recovery 
 
Tosun et al. 2006 BW; two sessions of 
exercise bouts; 30 min 
walking, followed by 
walking with weight-
lifting (5kg) at 
submaximal intensity. 
Sessions were separated 
by period of 1 week 
Healthy and 
sedentary 
premenopausal 
women, 26-33 y 
N=9 
 
Plasma OC, PICP, ICTP, PINP, BAP No significant changes were 
observed with OC, PICP, 
ICTP and PINP 
BAP decreased 24 h post-
exercise in walking group 
BAP increased 24 h post-
exercise in walking with 
weight-lifting group 
 
Hermann et al. 2007 CY; 60 min at 75%, 95% 
and 110% VO2max 
 
Male and female 
athletes (MA, FA) 
and sedentary 
controls (MCo, 
FCo), 17-39 y 
N=32 
Serum CTX CTX increased in MA at 95% 
and 110% 
CTX decreased 24 h post-
exercise in MA, MCo and FA 
 
 
CY= cycling; BW= brisk walking; BAP= bone alkaline phosphatase; CTX= C-terminal of cross-linking telopeptide of type 1 collagen; OC= osteocalcin; 
PICP= propeptide of type 1 collagen; PIIIP= propeptide of type 3 collagen; ICTP= Pyridinoline cross-linked carboxy-terminal telopeptide of type I 
collagen; VT= ventilator threshold 
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 1.7.2 Exercise and inflammation 
Exercise is a form of physical stress that affects all compartments of the body, including 
the immune system. Thus cytokines, as regulators of the immune system, are significantly 
influenced by exercise (Spanoudaki et al., 2010). It is well established in the literature 
that regular exercise improves inflammatory status and decreases the risk of 
inflammatory and metabolic conditions (Gleeson et al., 2011). In fact, regular exercise is 
associated with many anti-inflammatory effects, such as decreased expression of 
macrophages, decreased adipose tissue infiltration, and decreased production of pro-
inflammatory monocytes (Gleeson et al., 2011).  
As seen with regular exercise, acute exercise also acts as a physical stressor that 
stimulates numerous metabolic and physiological changes. The most common anti-
inflammatory changes reported after strenuous exercise include decreases in neutrophil, 
lymphocyte, and macrophage function (Neto et al., 2011; Nieman et al., 2007). 
Furthermore, acute exercise modifies the circulating levels of many cytokines including 
IL-1α, IL-1β, IL-6, TNF-α and IL-10. A list of studies on the effects of acute exercise on 
these cytokines is provided in Table 3. As shown in Table 3, an acute bout of exercise is 
generally immediately followed by moderate increases in IL-1α, IL-1β and TNF-α, and a 
substantial increase in IL-6 peaking towards the end of the exercise (Scott et al. 2011; 
Pedersen & Toft, 2000). These cytokines remain elevated for approximately an hour after 
exercise before returning to their baseline values. An anti-inflammatory effect is observed 
with a delayed increase of IL-10 usually occurring at least 1 hour after exercise (Peterson 
& Pederson 2005). Figure 6 illustrates the cytokine response during high-intensity 
exercise.  
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These findings are consistent in both high-impact and low-impact exercise 
protocols (LaVoy et al., 2013; Nieman et al., 2007; Zaldivar et al., 2006). Studies 
utilizing high-impact (ie. treadmill running) and low-impact exercise (ie. cycling) 
reported similar increases of TNF-α and IL-6 during or immediately after exercise 
(Otrowski et al., 1999; Scott et al., 2013; Spanoudaki et al., 2010; Zaldivar et al., 2006). 
However, the cytokine response seems to differ between exercises that focus on 
concentric muscle contractions (shortening of muscle fibers) as opposed to eccentric 
muscle contractions (elongation of muscle fibers). Eccentric contractions are associated 
with increased muscle damage resulting in a prolonged rise in pro-inflammatory cytokine 
secretion (Rohde et al., 1997).  The effect of eccentric contractions on TNF-α and IL-6 
secretion has been demonstrated in exercise studies (Bruunsgaard et al., 1997).  
 Furthermore, as shown in Table 3, studies reporting significant cytokine 
variations utilized exercise durations ranging from 3 minutes to 2 hours of exercise 
(Cannon et al., 1991; Ostrowski et al., 1998; Ullum et al., 1994). This is also supported 
by a cross-over study that examined the cytokine response after two cycling protocols of 
different duration (Nieman et al., 2007). One protocol consisted of 2 hours of continuous 
cycling whereas the other protocol consisted of 10-minute bouts of exercise separated by 
3 minutes rest. This study reported similar cytokine responses for both exercise durations 
thereby indicating the cytokine response may be more sensitive to the intensity of the 
exercise (with high-intensity exercise producing pronounced changes in cytokine levels) 
as opposed to exercise duration (Nieman et al., 2007).  
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Table 3: Studies on the effects of acute exercise on pro-inflammatory and anti-inflammatory cytokines. 
Publication Exercise Mode Participants Method Outcome Measures Results 
Canon et al. 1986 CY; 1 h at 60% 
VO2max 
 
Male, age 20-36 yr 
n=8 
Plasma IL-1 IL-1β increased 3 h post-
exercise 
 
Evans et al. 1986 EE (leg); 45 min at 250 
W (42% VO2max 
untrained, 27% VO2max 
runners) 
Untrained men (n=5) 
and highly trained 
endurance runners 
(n=4) 
 
Plasma, IL-1β IL-1β increased 3 h post-
exercise in untrained men 
Dufaux & Order, 
1989 
RU; 2.5 h Male, sports 
students, 20-28 yr 
n=8 
 
Plasma TNF-α TNF-α increased 1 h post-
exercise 
Esperson et al. 1989 
 
RU; 5 km Elite runners 
n=11 
Plasma TNF-α TNF-α increased 2 h post-
exercise; returned to baseline 
after 24 h 
 
Canon et al. 1991 TR; three 15-minute 
periods 75% VO2max, 
separated by 5 min rest  
Sedentary adult 
males, 25-65 yr 
Cell culture 
supernatant 
IL-1β, TNF-α, IL6 IL-1β and TNF-α increased 
24 h post-exercise 
 
 
Sprenger et al. 1992 RU; 20 km Long distance 
runners; males 
(n=14), females 
(n=8), 28-54 yr 
 
Plasma, 
Urine 
IL-1, IL-6, TNF-α TNF-α increased immediately 
post-exercise,  
Ullum et al. 1994 CY; 1 h at 75% VO2max Healthy, young 
moderately trained 
males, 29-39 yr 
n=17 
Plasma IL-1α, IL-1β, IL-6, TNF-α IL-6 increased during exercise, 
and returned to/below baseline 
1 h post-exercise 
IL-1α, IL-1β, and TNF-α 
were not detectable in plasma 
 
Castell et al. 1996 RU; 3.45 h marathon 
running (43 km) 
Male athletes, 
20-40 yr 
Plasma TNF-α, IL-6 IL-6 increased immediately 
and 1 h post-exercise 
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n=12 
 
Bruunsgaard et al. 
1997 
CY; 1st session of 30 min 
concentric exercise 
(normal cycling) at 65% 
VO2max, 2nd session of 
EE (reversed cycling) of 
30 min at 100-150% 
VO2max 
Sessions were separated 
by 2 weeks 
 
Healthy young 
males 
n=9 
Serum IL- β, TNF-α, IL-6 IL-6 increased 2 h post-
eccentric exercise 
Venkatraman & 
Pendergast, 1998  
Running; 40-80% 
VO2max until voluntary 
exhaustion 
Runners; males 
(n=10), females 
(n=10), 32-38 yr 
Plasma IL-1β, IL-6, and TNF-α IL-6 decreased post-exercise 
(time not specified) 
 
 
Ostrowski et al. 
1998 
TR; 2.5 h at 75% 
VO2max 
Male athletes 
n=10 
Plasma IL-1β, IL-6, TNF-α IL-6 increased at 30 min of 
exercise and 1 h post-exercise 
and remained higher than 
baseline 6 h post-exercise 
 
Ostrowski et al. 
1999 
RU; 3.26 h marathon 
running 
Male volunteers,  
24-37 yr 
n=10 
Plasma TNF-α, IL-6, IL-1β, IL-10 TNF-α increased immediately 
post-exercise and remained 
higher than baseline up to 2.5 
h post-exercise 
IL-6 increased immediately 
post-exercise and remained 
higher than baseline up to 4 h 
post-exercise 
 
Steensberg et al. 
2001 
Running; 2.5 h at 75% 
VO2max 
Male runners, 25-50 
y 
n=9 
Plasma IL-6 IL-6 increased during exercise 
and 30 min post-exercise 
before returning to baseline 
 
Chan et al. 2004 CY; 1 h at 70% VO2max Active males, 22-26 
n=8 
Plasma 
 
IL-1β, IL-6 IL-6 increased 40 min post-
exercise 
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Zaldivar et al. 2006 Cycling; 30 min at 80% 
VO2max 
Healthy male adults, 
18-30 y 
n=11 
Serum IL-1α, IL-6, IL-10, TNF-α IL-1α, IL-6, and TNF a 
increased immediately post-
exercise 
IL-6 continued to increase 1 h 
post-exercise 
IL-10 increased 1 h post-
exercise 
TNF-α decreased 1 h post- 
exercise 
 
Nieman et al. 2007 CY; 1st session of 
continuous cycling at 
64% VO2max for 2 h; 
2nd session of 
intermittent exercise at 
64% VO2max separated 
by 3-min of rest every 10 
min 
 
 
Trained cyclists 
n=12 
Plasma IL-6, IL-10 IL-6 and IL-10 increased 
immediately post-exercise 
IL-6 decreased 1 h post 
exercise 
IL10 increased 1 h post 
exercise 
 
No difference between 
sessions 
 
Croft et al. 2009 TR; Five 3-min bouts at 
90% VO2max, separated 
by 3-min active recovery 
periods  
Recreationally active 
males 
n=? 
Plasma/Serum IL-6 and  TNF -α IL-6 increased immediately 
post-exercise 
TNF-α did not change with 
exercise 
 
Spanoudaki et al. 
2010 
CY; 1st session of 
intermittent cycling for 1 
h between 47-120% 
VO2max, 2nd session of 
constant cycling for 1 h 
at 105% VO2max (24 h 
apart) 
Healthy, moderately 
trained men 
n=10 
Serum TNF-α, IL-6 No difference in TNF-α and 
IL-6 between exercise 
protocols 
TNF-α and IL-6 increased 
during 30 and 60 min of 
exercise, and returned 
to/below baseline 1 h post-
exercise 
 
Scott et al. 2011 TR; 3 sessions of 1 h at 
55%, 65%, and 75% 
Physically active 
men 
Plasma/Serum TNF-α, IL-1β, IL-6 TNF-α increased 1 h and 1.5 
h post-exercise at all 
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VO2max  
Sessions separated by 1 
week 
n=10 intensities 
IL-6 increased during exercise 
at all intensities (at higher 
concentration with higher 
intensity) 
 
LaVoy et al. 2012 Cycling; 1 h at 95% 
VO2max 
Trained male 
cyclists, 28-38 y 
n=16 
Cell culture Expression of TNF-α, IL-6, 
IL-10 by CD8+ T-cells 
TNF-α, IL-6, and IL-10 
increased 1 h post-exercise 
 
 
Scott et al. 2013 TR; 1 h of continuous 
running at 65% 
VO2max, followed 
intermittent to 
exhaustion at 70% 
VO2max 
Recreationally active 
men (n=11) and 
endurance trained 
men (n=10) 
Plasma/Serum TNF-α, IL-1α, IL-1β, IL-6 TNF-α increased during and 
post-continuous exercise and 
up to 2 h post-intermittent 
exercise 
IL-1α increased 1 h post-
continuous exercise and 
remained higher than baseline 
24 h post 
IL-1β increased during and 
immediately after continuous 
and intermittent exercise  
IL-6 increased 
throughout/after constant 
running and up to 24 h post-
exercise 
 
Kerasioti et al. 2013 CY; 2 h at 60-65% 
VO2max, followed by 4 
h recovery, and 1 h 60-
95% VO2max 
 
Physically active 
men, 26-30 yr 
n=9 
Plasma IL-6, IL-10 IL-6 increased 30 min post-
exercise and up to 24 h post-
exercise 
 
 
CY= cycling; RU= running; TR= treadmill running; EE= eccentric exercise 
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1.8 Interaction between bone and cytokines in exercise 
 
Based on the current literature, it is apparent that exercise stimulates perturbations in 
bone turnover and cytokine levels. With respect to low-impact exercise, the duration of 
exercise may have greater effects on bone turnover in comparison to other factors 
Figure 6 Effects of High-intensity exercise on cytokine levels. Based on previous studies 
that assessed the effects of exercise on the cytokine response (as presented in Table 3), pro-
inflammatory cytokines are found to increase shortly or immediately after exercise, followed 
by anti-inflammatory cytokines (Pederson & Toft, 2000, Pederson & Peterson 2005). 
Elevations in IL-6, IL-1α, IL-1β, and TNF-α are all hypothesized to increase 5-minutes post 
exercise as they have been reported to increase immediately post-exercise by Otrowski et al. 
(1999), Scott et al. 2011, and Pederson & Toft (2000). Changes in IL-10 are usually delayed 
have been reported to increase between 5-minutes to 1-hour post-exercise (Lavoy et al. 2012; 
Neiman et al. 2007). All cytokines have been shown to decline or return back to baseline at 
least a couple of hours post-exercise in most studies (not shown in figure) (Esperson et al. 
1989; Spanoudaki et al. 2010; Otrowski et al. 1999; Peterson & Pederson 2000) 
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(Maumoun et al. 2006), while the cytokine response may be more sensitive to exercise 
intensity (Nieman et al. 2007) as observed in Tables 2 and 3. 
 The mechanisms that contribute to the effects of bone turnover and cytokine 
responses, respectively, have been well established in the literature. Bone turnover has 
been shown to be primarily influenced by mechanical strain and variations in parathyroid 
hormone, growth hormone, testosterone, and leptin, all of which are upregulated during 
exercise (Bouassida et al., 2006; Wallace et al., 2000; Yakar et al., 2002; Hough et al., 
2011; Bergnan et al., 2013). The cytokine response during exercise has been attributed 
mostly to the stimulation of lymphoid organs, production of cytokines in muscle and 
adipose tissue, and glucocorticoid and catecholamine production by the hypothalamic 
adrenal axis (Singh et al., 1998; Neto et al., 2009; Steensberg et al., 2002). All of these 
mechanisms stimulate bone turnover and cytokine production during exercise, however 
what happens beyond this point between cytokines and bone is unclear due to the lack of 
literature investigating this relationship. As previously discussed, bone cells and their 
precursors are capable of responding to cytokines as well as producing them. Therefore it 
is possible that local and systemic cytokines (which increase with exercise) may interact 
with bone thereby also manipulating the bone turnover response to exercise. Figure 6 
illustrates the possible interaction between cytokines and bone during and before high-
intensity exercise with association to time. Based on the sequence of cytokine level 
variations depicted in Figure 5, the initial pro-inflammatory cytokine response may 
initially result in greater bone resorption by upregulating RANKL, increasing osteoclast 
proliferation, and inducing and osteoblast differentiation, all of which have been shown 
to be induced by TNF-α, IL-6, IL-1α, and IL-1β with in vitro applications (Schett, 2011; 
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Takayanagi, 2012; Walsh et al., 2006). After the end of the exercise, the increase in  
pro-inflammatory response by IL-10 may stimulate bone formation by inhibiting RANKL 
expression (Hong et al., 2000). Based on these postulations, it is expected that low-
impact, high-intensity exercise may initially be accompanied by an increase in bone 
resorption markers, followed by increased bone formation markers in serum.  Due to the 
large discrepancies found in the literature pertaining to high-intensity, low-impact 
exercise and bone turnover, it is difficult to conclude whether these sequence of events 
may in fact be the case. Thus more studies are required that investigate the effects of 
high-intensity, low-impact exercise on bone formation and bone resorption markers. In 
addition, a comprehensive examination of the changes in cytokines and bone turnover 
markers with respect to each other is needed to understand the interaction between 
cytokine and bone in exercise.  
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Figure 7 Possible associations between cytokines and bone in response to HIE and the 
possible net effect on bone turnover. The onset of high intensity exercise leads to cytokine 
production by various compartments in the body. According to Pederson & Toft (2000) the first 
source of cytokine production during exercise starts from skeletal muscle. Contracting muscle 
fibers produce IL-6 locally and eventually systemically as IL-6 leaks out from the tissue. Damage 
in the muscle caused by contractions leads to the recruitment of monocytes and macrophages, 
which increases the production of IL-1 and TNF-α. TNF-α secretion may also originate from 
the liver and adipose tissue, both of which are stimulated by circulating LPS levels which 
increase with exercise (Scott et al., 2011). Another source of TNF-α  is monocytes and 
macrophages that are stimulated of HPA during exercise, however this contribution is minimal 
given that the secretion of TNF-α by these cells is very low. Finally, increases in IL-10 are 
stimulated by the HPA as well as lymphoid organs, such as the spleen. Based on previous studies 
that have assessed the effects of cytokine on bone with in vivo and in vitro studies, it is very likely 
that the cytokine response during exercise will also govern the magnitude of bone formation and 
primarily bone resorption. 
 
 43 
Chapter 2: Proposed Study 
 
2.1 Rationale 
Regular exercise improves bone health by increasing bone mineral density and bone 
strength (Maimoun & Sultan, 2011). Current dogma is that long-term exercise maintains 
or improves BMD and lowers the risk of fracture and development of osteoporosis in 
adults (Korpelainen et al., 2010; Andreoli et al., 2011; Kemmler et al., 2012; Guadalupe-
Grau et al., 2009; Cousins et al., 2010; Lofgren et al., 2012). However, the acute bone 
response to a single bout of exercise is less clear (Maimoun & Sultan, 2011). Recently, 
short bouts of exercise in the form of high-intensity interval exercise (HIE) have been 
receiving scholarly attention for their ability to induce of a number of metabolic 
adaptations associated with conventional long-term exercise (Gibala & McGee, 2007). 
Simultaneously, evidence from in vitro bone models suggests that intermittent exercise 
(as observed with the intermittent application of exercise-induced systemic factors) may 
produce anabolic effects on bone (Maimoun et al., 2006). However, the use of HIE as an 
intermittent form of exercise on bone has not been established. Given the short duration 
of HIE, the application of this form of exercise may pose greater convenience in today’s 
predominantly busy lifestyles. Consequently, HIE may be used by healthy and clinical 
populations to maintain or improve bone health. 
Osteoblasts (bone forming cells) and osteoclasts (bone resorbing cells) are two 
key players in bone remodeling, thus examining how biochemical markers of bone 
formation and resorption respond to acute exercise is an important step in identifying the 
mechanisms of the bone response to exercise. Furthermore, osteoblasts and osteoclasts 
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are mediated by many systemic factors such as cytokines. Cytokines, both pro-
inflammatory and anti-inflammatory, play a very important role in bone formation and 
resorption (Takayanagi, 2007). This has been shown by clinical studies in which patients 
with bone conditions such as arthritis present an imbalance of pro-inflammatory and anti-
inflammatory cytokines in association with poor bone health (Schett, 2011; Takayanagi, 
2012). Cytokine levels are altered by exercise, resulting in an improved inflammatory 
profile with the increased levels of anti-inflammatory cytokines outlasting pro-
inflammatory cytokine levels (Ullum et al., 1994). However, although markers of bone 
turnover and cytokines have been assessed following single bouts of different exercise 
protocols independently, there is a paucity of data regarding whether the cytokine 
response is associated with the bone turnover response following exercise and especially 
HIE. The interconnected relationship between bone and cytokines has been well 
illustrated with various models such as in vitro and in vivo animal studies (Lee et al., 
2008; Takayanagi 2007), however it has not been explored in an exercise model. 
Investigating the association between changes in bone markers and cytokines may be 
beneficial in understanding how exercise affects each compartment.  
Bone is very dynamic and sensitive to mechanical stimulation. In fact, high-
impact exercise may stimulate local bone turnover markers from the site of mechanical 
loading (Bloomfield, 2001). Therefore, in order to characterize the systemic effects of 
exercise rather than mechanical loading on markers of bone turnover and cytokines and 
their potential association, a mode of HIE needs to be assessed that is low-impact and 
utilizes minimal weight-bearing activity. One such exercise is cycling (Guillemant et al., 
2004).  
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2.2 Objectives and Hypotheses 
 
2.2.1 Objectives 
The overall objective of this study was to investigate the bone turnover and cytokine 
response to a single bout of low-impact, high intensity exercise (HIE). The specific 
objectives were to:  
 Examine the magnitude and timing of post-exercise changes in bone 
formation and bone resorption markers.  
 Examine the magnitude and timing of post-exercise changes in pro- and 
anti-inflammatory cytokines.  
 Determine if there is an association between the percent changes of bone 
turnover markers and cytokines across different time points after exercise.  
 
2.2.2 Hypotheses 
 
The overall hypothesis of this study is that a single bout of HIE would induce a bone 
turnover and cytokine response similar to prolonged exercise with levels increasing 5min 
post-exercise and slowly returning to baseline levels 24hr following the exercise. The 
specific hypotheses were: 
 an acute bout of HIE would stimulate an increase in bone turnover 
markers 5min post exercise with levels slowly returning to baseline levels 
24hr following the exercise; 
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 an acute bout of HIE would lead to increased pro- and anti-inflammatory 
cytokine levels 5min post exercise with levels slowly returning to baseline 
levels 24hr following the exercise; 
 the post-exercise changes in markers of bone turnover would be associated 
with changes in the pro- and anti-inflammatory cytokines.  
 
2.3 Implications 
By investigating the combined effects of a single bout of HIE on markers of bone 
turnover and cytokine levels, we could postulate whether a post-exercise association 
exists between the immune and bone response to low-impact, high intensity exercise. 
This investigation may pave the way to establish mechanistic studies that further explore 
these associations and elucidate the mechanisms in which bone and cytokine interact 
during exercise. Furthermore, exploring the effects of HIE on bone health and 
inflammatory status may provide evidence to encourage the use of HIE as a mode of 
maintaining bone health and preventing the development of osteoporotic conditions in 
both healthy and clinical populations.  
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Chapter 3: Methods 
 
3.1 Subjects 
Twenty-three young males (mean ± SD, age 21.8 ± 2.4 y, weight 76.63± 11.7 kg) were 
voluntarily recruited from Brock University to participate in the study. The sample size 
was chosen in accordance with previous studies (outlined in Tables 1 and 2) that utilized 
cycling as a mode of exercise for assessing levels of bone markers or cytokines. 
Participants were recruited through class announcements during the academic year. 
Participants provided informed consent during their first visit and filled out the Medical 
History Questionnaire and the Godin-Shephard Leisure-Time Exercise Questionnaire. 
The latter is a simple questionnaire that assesses leisure time exercise behavior, in which 
the responses are converted into metabolic equivalents (MET) (Godin & Shephard, 
1985). No medical conditions were reported and participants refrained from smoking and 
alcohol consumption prior to and during their visits. These subjects were recreationally 
active, with a mean weekly physical activity score of 66.1± 28.2 MET. All subjects were 
asked to refrain from strenuous physical activity 24h prior to HIT trial and between the 
third and last blood sample collection.  
 
3.2 Exercise Protocol 
The study consisted of 3 visits on separate days between 12:30-3:00 PM. During the first 
visit participants provided informed consent and performed an incremental test on a cycle 
ergometer to measure their maximum workload. The exercise started with a 5-minute 
warm-up session of cycling at 80 W, followed by the incremental test in which the 
resistance was increased by 15 W every minute. Participants cycled until exhaustion, and 
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maximum workload was recorded. Heart rate was monitored continuously throughout the 
test in order to record working intensity. On the second visit, participants performed the 
HIE trial based on the cycle ergometer at 90% of the maximum workload. The trial 
involved 12 minutes of intermittent cycling consisting of six 1-minute high-intensity 
cycling intervals separated by six 1-minute active rest periods. During the active rest 
periods, participants were allowed to cycle in the opposite direction (which eliminates 
resistance) or pause completely on the cycle ergometer. The HIE trial was initiated with a 
4-minute warm-up which consisted of cycling at 25%, 50%, 75% and 100% of their 
maximum workload per minute. The trial was followed by a cool-down period of 2-3 
minutes that consisted of cycling at 70 W.  
 
3.3 Blood Collection 
Blood was drawn from the participants at four times points: pre-exercise (baseline), 5min 
post-exercise, 1h post-exercise and 24h post-exercise. Blood was drawn from the 
antecubital vein using 21 G BD Vacutainer® with subjects in a seated position. Blood 
was transferred into clear serum tubes (BD Vacutainer®) and allowed to clot for 60 
minutes. The tubes were transferred to a pre-cooled centrifuge (Thermo Scientific®) and 
were spun at 4°C and 3000 RPM for 15 minutes. Serum was collected from the tubes and 
stored in plastic Eppendorf® tubes at -70°C. 
 
3.4 Biochemical Assessments 
All bone markers were assessed using enzyme-linked immunosorbent assays (ELISA). 
ELISA is a highly sensitive immunoassay utilizing enzyme-conjugated antibodies, with 
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antigen or antibodies bound to a solid support. The assay measures changes in enzyme 
activities proportional to the antigen or antibody concentrations involved in the 
underlying immune reactions. The results of the bone marker assays were assessed using 
a Bio-Tek spectrometer and KC4 (3.3) Software, while cytokines were assessed using the 
Magpix reader and Luminex Software.  
 
3.4.1 NTx (Osteomark® NTx Serum kit, Alere) 
All samples and reagents were allowed to equilibrate to room temperature before being 
used. Working strength solution was prepared by diluting 30X Wash Concentrate 1:30 
with deionized water and mixed for a minimum of five minutes. The work strength 
conjugate solution was also prepared by diluting the Antibody Conjugate Concentration 
to a 1:101 ratio using Antibody Conjugate Diluent. The solution was mixed gently. The 
calibrators, controls and specimens were thoroughly mixed and then subsequently diluted 
to a 1:5 ratio with Specimen Diluent. The samples were then mixed thoroughly and then 
100 μl of each sample was pipetted into a 96-well plate using a multichannel pipette. 
After this step, 100 μl of working strength conjugate solution was pipetted into each 
microwell. The plate was then incubated at room temperature (20-25°C) for 90 minutes. 
After the incubation, the microwells were washed manually five times with the working 
strength wash solution and blotted after the final wash. Once the strips were dry, the 200 
μl of Chromagen Reagent/Buffered substrate solution, which was prepared by diluting 
Chromagen Reagent into the Buffered substrate solution at a ratio of 1:101, was 
immediately pipetted into the microwells. The plate was then incubated at room 
temperature for 30 minutes. After incubation, 100 μl of Stop solution was added to each 
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microwell. The plate was then swirled gently for 15-20 seconds and subsequently 
incubated for 5 minutes at room temperature. Following incubation, the absorbance of the 
calibrators, controls and specimens was read using a plate reader at an absorbance of 450 
nm. A standard calibration curve was generated using a polynomial curve fitting 
equation. The minimum detectable concentration measured with the NTx assay is 3.2 nM. 
 
3.4.2 BAP (Ostase® BAP Serum kit, Immunodiagnostic Systems) 
All reagents were brought to room temperature and thoroughly mixed prior to use. Wash 
solution was prepared by diluting 50 ml of Wash Concentrate with 950 ml of distilled 
water. 50 μl of the zero calibrator, calibrators B-F, controls and specimens were pipetted 
into the bottom of each assigned well. Then 100 μl of conjugate solution was pipetted 
into all microwells. The plate was then incubated for 1 hour at room temperature on a 
horizontal rotator set at 500 rpm. After incubation, 100 μl of Quench reagent was added 
to each microwell. Within 5 minutes of adding the reagent, the absorbance of the plate 
was read at 405 nm. A standard curve was generated using a polynomial curve fitting 
equation. The minimum detectable concentration measured with the BAP assay is 0.7 
μg/l. 
 
3.4.3 OPG (Human OPG Elisa kit, BioVendor®) 
All reagents were brought to room temperature and thoroughly mixed prior to use. 
Samples were diluted 3x with Dilution Buffer just prior to the assay. After sample 
preparation, 100 μl of diluted standards, quality controls, dilution buffer, and samples 
were pipetted into microwells. The plate was incubated for 1 hour at room temperature 
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while shaking on an orbital plate shaker at 300 rpm. After incubation, the plate was 
washed three times with Wash solution and blotted at the final wash. Once the plate was 
dried, 100 μl of Biotin Labeled Antibody was pipetted into each microwell. The plate was 
incubated again at room temperature for 1 hour while shaking on an orbital plate shaker 
at 300 rpm. The plate was washed again as previously described. 100 μl of Streptavidin-
HRP Conjugate was added into each microwell, and the plate was incubated at room 
temperature for 30 minutes while shaking on an orbital plate shaker at 300 rpm. After 
incubation, the plate was washed three times with Wash solution and blotted at the final 
wash. 100 μl of Substrate Solution was added into each microwell. The plate was then 
sealed and covered with aluminum foil and incubated for 10 minutes at room temperature 
without shaking. The colour development was interrupted by adding 100 μl of Stop 
Solution. The absorbance of the plate was subsequently read by a plate reader at an 
absorbance of 450 nm. A standard curve was generated using a polynomial curve fitting 
equation. The minimum detectable concentration measured with the OPG assay is 0.03 
pmol/l. 
 
3.4.4 RANKL (Human sRANKL Elisa, BioVendor®) 
All reagents were brought to room temperature and were thoroughly mixed before use. 
Samples were diluted 100x with Dilution Buffer. After sample preparation, 100 μl of 
Standards, Quality Controls, Dilution Buffer and samples were pipetted into microwells. 
The plate was incubated for 18 hours at 2-8°C while shaking on an orbital plate shaker at 
300 rpm. After incubation, the plate was washed 5 times with Wash Solution, and blotted 
after the final wash. 100 μl of Streptavidin-HRP Conjugate was added into each 
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microwell, and the plate was incubated at room temperature for 1 hour while shaking on 
an orbital plate shaker at 300 rpm. After incubation, the plate was washed three times 
with Wash solution and blotted at the final wash. The plate was washed 100 μl of 
Substrate Solution was added into each microwell. The plate was then sealed and covered 
in aluminum foil and incubated for 25 minutes at room temperature without shaking. The 
color development was interrupted by adding 100 μl of Stop Solution. The absorbance of 
the plate was subsequently read by a plate reader at an absorbance of 450 nm. A standard 
curve was generated using a polynomial curve fitting equation. The minimum detectable 
concentration measured with the RANKL assay is 0.4 pmol/l. 
 
3.4.5 Cytokines (Milliplex® MAP kit, Millipore).  
The cytokines were assessed using the Milliplex® MAP, which is based on Luminex 
xMAP technology. Luminex uses proprietary techniques to internally color-code 
microspheres with two fluorescent dyes. Through precise concentrations of two dyes, 100 
distinctly colored bead sets can be created, each of which is coated with a specific capture 
antibody. This system allows you to detect multiple analytes simultaneously. The 
Milliplex® MAP kit used in this assay measured cytokine concentrations of IL-10, IL-1α, 
IL-1β, IL-6 and TNF-α. 
All reagents were brought to room temperature and were thoroughly mixed before 
use. The assay was initiated by adding 200 μl of Wash Buffer into each well of the plate. 
The plate was sealed and placed on an orbital plate shaker for 10 minutes at room 
temperature. The Wash Buffer was then decanted and residual amounts were removed by 
inverting the plate and blotting it on absorbent towels. Then, 25 μl of each Standard and 
 53 
Control was pipetted into the appropriate wells. 25 μl of Assay Buffer was then added to 
the sample wells, followed by adding 25 μl of Serum Matrix Solution to the background, 
standards, and control wells.  The samples were then added by pipetting 25 μl of the 
serum into the appropriate wells. 25 μl of Mixed Beads, that were prepared prior to the 
assay, were pipetted into all the wells. The plate was then sealed and covered with foil 
and incubated for 2 hours at room temperature while shaking on an orbital plate shaker at 
300 rpm. After incubation, the plate was attached to a plate magnet and inverted to 
remove well contents. The plate was then washed 2 times and blotted gently on absorbent 
paper while still attached to the magnet. 25 μl of Detection Antibodies were pipetted into 
each well, and the plate was subsequently sealed and covered with foil and placed on an 
orbital plate shaker for 1 hour at room temperature. 25 μl of Streptavidin-Phycoerythrin 
was pipetted into the wells containing the Detection Antibodies, and the plate was 
subsequently sealed and covered with foil and placed on an orbital plate shaker for 30 
minutes at room temperature. After incubation, the plate was attached to a plate magnet 
and inverted to remove well contents. The plate was then washed 2 times and blotted 
gently on absorbent paper while still attached to the magnet. 150 μl of Drive fluid was 
pipetted in all the wells and the plate was placed on an orbital plate shaker for 5 minutes. 
The plate was then run on the Luminex software. Cytokine concentrations were 
determined by analyzing the Median Fluorescent Intensity (MFI) data using a 5-
parameter logistic plate curve-fitting method. The minimum detectable concentrations for 
the cytokines measured with this assay are 1.5 pmol/l of IL-1α, 0.7 pmol/l of IL-1β, 0.4 
pmol/l of IL-6, 0.3 pmol/l of IL-10 and 0.3 pmol/l of TNF-α. 
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3.5 Statistical Analysis 
The results were analyzed using SPSS Statistics (Version 21). Descriptive statistics were 
run to determine normal distribution. All bone marker data were normally distributed, 
therefore repeated measures analysis was computed to determine significant time effects.  
Although cytokine levels were assessed in all samples collected, in some samples 
not all cytokines were detectable. To control for missing data, a list-wise deletion was 
applied so that subjects with missing cytokine values were omitted when running the 
repeated measures model. The final number of subjects that had valid values for all time 
points and used in the analysis of each cytokine were: n=10 for IL-1α, n=8 for IL-1β, n=9 
for IL-6, n=15 for TNF-α, and n=12 for IL-10. Due to this small sample size, the cytokine 
data were not normally distributed. Thus, non-parametric tests were computed to assess 
whether there was a significant time effect associated with cytokines and exercise 
(Friedman Test) and to determine the time points responsible for these effects (Wilcoxon 
Signed Rank Test).  
 Finally, the relationship between bone markers and cytokines was assessed. 
Percent changes from baseline were calculated for all markers and were used to examine 
the association between cytokines and bone markers using a Pearson correlation. Values 
are presented as mean ± SEM and significance was accepted at p<.05. 
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Chapter 4: Results 
 
 
4.1 Physical Characteristics  
The physical characteristics of the subjects are reported in Table 4. Subjects cycled at an 
intensity of 261.3W± 41.0W at 90% of maximum workload, with heart rate values 
ranging from 175-185 beats per minute (BPM) throughout working intervals.  
 
 
Table 4: Physical Characteristics of Participants (n=23) 
 Mean  ± SD 
Age (y) 21.8 ± 2.4 
Weight (kg) 76.6 ± 11.7 
Height (cm) 178.6 ± 6.7 
BMI (kg/m2) 23.9 ± 2.5 
Percent Body Fat (%) 10.5 ± 5.5 
Fat Free Mass (kg) 68.2 ± 8.9 
Physical Activity Score 66.6 ± 28.2 
BMI= body mass index 
 
 
4.2 Baseline and post-exercise values of bone turnover markers 
 
The baseline and post-exercise values for bone markers are reported in Figures 8-11. 
There was a significant time effect for all bone turnover markers (p=0.002). At 5min 
post-exercise, BAP (Figure 9), OPG (Figure 10), and RANKL (Figure 11) significantly 
increased from baseline values (10.5, 11.8 and 19.7%; p=0.001, p=0.001 and p=0.000, 
respectively). At 1h post-exercise, only BAP was significantly higher than baseline 
(9.0%; p=0.010), while the other markers returned to baseline values. At 24h, BAP 
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remained significantly higher than baseline (10.7%, p=0.001) while NTX was 
significantly decreased from baseline (-12.10%, p=0.046) (Figure 8).  
 
 
Figure 8: Serum concentrations of NTX at baseline, 5 minutes, 1 hour and 24 hours post-
exercise. *p<.05 from all other time points. Values are presented as mean ± SE. 
 
 
 
 
Figure 9: Serum concentrations of BAP as baseline, 5 minutes, 1 hour and 24 hours post-
exercise. *p<.05 from baseline. Values are presented as mean ± SE. 
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Figure 10: Serum concentrations of OPG at baseline, 5 minutes, 1 hour and 24 hours post-
exercise. *p<.05 from baseline and 24 h. Values are presented as mean ± SE. 
 
 
 
 
 
Figure 11: Serum concentrations of RANKL at baseline, 5 minutes, 1 hour and 24 hours post-
exercise. *p<.05 from all other time points. Values are presented as mean ± SE. 
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4.3 Baseline and post-exercise values of cytokines 
The baseline and post-exercise values of cytokines are illustrated in Figures 12-16. A 
significant time effect was observed for IL-1α (p<0.00) (Figure 12), IL-1β (p=0.04) 
(Figure 13), IL-6 (p=0.03) (Figure 15), and TNF-α (p<0.00) (Figure 16). At 5min post-
exercise, IL-1α, IL-1β, IL-6, and TNF-α increased significantly from baseline (40.3%, 
41.3%, 70% and 76% respectively). IL-1α, IL-6, TNF-α decreased significantly 1h post-
exercise, and IL-1β only began to significantly decrease 24h post-exercise. No significant 
changes were observed with levels of IL-10 (Figure 14). 
 
 
Figure 12: Serum concentrations of IL-1α at baseline, 5 minutes, 1 hour and 24 hours post-
exercise. *p<0.05 from all other time points. Values are presented as mean ± SE (n=10). 
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Figure 13: Serum concentrations of IL-1β at baseline, 5 minutes, 1 hour and 24 hours post-
exercise. #p<0.05 from 24 h. Values are presented as mean ± SE (n=8). 
 
 
 
Figure 14: Serum concentrations of IL-10 at baseline, 5 minutes, 1 hour and 24 hours post-
exercise (n=12).  
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Figure 15: Serum concentrations of IL-6 at baseline, 5 minutes, 1 hour and 24 hours post-
exercise. ##p<0.05 from 1h and 24h. Values are presented as mean ± SE (n=9). 
 
 
 
Figure 16: Serum concentrations of TNF-α at baseline, 5 minutes, 1 hour and 24 hours post-
exercise. *p<0.05 from all the other time points. Values are presented as mean ± SE (n=15) 
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4.4 Correlations between bone markers and cytokines 
The correlations of percent changes between cytokines and bone markers are reported in 
Figures 17-20. At 5-minutes post-exercise, a significant correlation was observed 
between the percent changes in BAP and IL-10 (r=-0.68, r2=0.47 p=0.02) (Figure 17). At 
24-hours post-exercise, significant correlations were also observed between percent 
changes in BAP and IL-1α  (r=-0.69, r2=0.47, p=0.04) (Figure 18), OPG and IL-10 
(r=0.64, r2=0.41, p=0.03) (Figure 19), and NTX and TNF-α (r=0.66, r2=0.43, p=0.008) 
(Figure 20).  
 
 
 
Figure 17: Correlation between percent changes in BAP and IL-10 from pre- to 5-minutes post-
exercise (n=11).  
 
0
2
4
6
8
10
12
14
16
-80 -60 -40 -20 0 20 40 60 80 100
B
A
P
 (
μ
g
/L
)
IL-10 (pmol/L)
r= -0.68 
r2= 0.47 
p=  0.02 
 
 62 
 
Figure 18: Correlation between percent changes in BAP and IL-1α from pre- to 24-hours post-
exercise (n=9).  
 
  
 
Figure 19: Correlation between percent changes in OPG and IL-10 from pre- to 24-hours post-
exercise (n=12). 
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Figure 20: Correlation between percent changes in NTX and TNF-α from pre- to 24-hours post-
exercise (n=15). 
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Chapter 5: Discussion and Conclusions 
 
5.1 Discussion 
The purpose of this study was to investigate the combined effects of low-impact HIE on 
pro- and anti-inflammatory cytokines and bone turnover markers. Young, recreationally 
active males participated in this study and performed a HIE protocol for a total duration 
of 12 minutes. It was found that although cycling is low-impact it does stimulate a bone 
turnover response as seen with the previous literature (Maimoun et al., 2006; Rudberg et 
al., 1999; Tosun et al., 2006; Wallace et al., 1999). The acute effects of HIE were found 
to be very similar to the previous literature with an initial rise in pro-inflammatory 
cytokines, followed by an increase in anti-inflammatory cytokines (Pederson & Toft 
2000). Finally, this study was the first of its kind to establish a significant correlation 
between the changes in bone markers and that of cytokines following high-intensity, low 
impact exercise. A summary of the findings of this study and the possible net effects on 
bone are depicted in Figure 21. 
 It is well documented that regular exercise improves inflammatory status and 
reduces the risk of inflammatory and metabolic conditions (Gleeson et al., 2011). As 
discussed earlier, acute exercise is associated with an initial increase in pro-inflammatory 
cytokines, followed by an increase in anti-inflammatory cytokines (Peterson & Pederson 
2000; Pederson & Toft, 2005). Indeed, IL-1α, IL-1β, IL-6 and TNF-α were found to 
increase significantly at 5 minutes post-exercise, while no significant effects were 
observed in the levels of IL-10 (Figures 12-16). The cytokine response to exercise has 
mainly been attributed to the marked increase in IL-6 towards the end of the exercise 
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(Pederson & Toft, 2000). Increases in IL-6 levels may be induced by local muscle 
production (due to muscle contractions), elevations in IL-1 and TNF-α that act on  muscle 
(due to damage caused by eccentric contractions), and by liver and adipose tissue (Rhode 
et al., 1997; Steensberg et al., 2002; Bruunsgaard et al., 1997; Scott et al., 2011). A few 
studies have shown that elevations liposaccharide (LPS) levels associated with exercise 
stimulates the secretion of TNF-α from liver and adipose tissue (Scott et al., 2011). IL-6 
stimulation by the IL-1 and TNF-α leads to the upregulation of their receptor antagonists, 
namely IL-1 receptor antagonists (IL-1ra) and soluble TNF-α receptors (sTNF-R), which 
increase immediately after IL-6 to act in a negative feedback mechanism to inhibit the 
pro-inflammatory effects of IL-1 and TNF-α  (Otrowski et al., 1998; Otrowski et al., 
1999; Pederson & Toft 2005). Therefore, the marked increase in IL-6 5-minutes post-
exercise may actually be critical for reducing the effects of other pro-inflammatory 
cytokines during exercise. Therefore, based on the cytokine changes that were observed 
after in the present study, our hypothesis depicted in Figure 7 may closely depict the 
sequence of cytokine release. It is important to note that increased levels of cytokines or 
other proteins (including bone turnover markers) could be due to increased production, or 
due to reduced protein clearance associated with exercise. Whether the observed 
increases in cytokines or bone markers are due to reduced clearance or increased 
production is undetermined in this study. It is possible to speculate that changes seen 
immediately at 5-minutes post-exercise are due to changes in protein clearance or 
changes in protein stability (reduced protein degradation) while the changes in 1-hour and 
24-hour after exercise may be due to both changes in synthesis/production as well as 
clearance/degradation. 
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Similar studies have been conducted in the past to evaluate effects of high-
intensity and low-impact exercise on bone, however many of the conclusions have been 
confounded by factors such as the intensity, duration, and type of exercise (Guillemant et 
al., 2004). To be consistent with the existing literature, this study utilized cycling as a  
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Figure 21 Reported associations between cytokines and bone in response to HIE and the net 
effect on bone turnover: An acute response was observed with pro-inflammatory cytokines, 
were found to increase 5-minutes post-exercise. As it was postulated, the increase in IL-1a, IL-1b, 
TNF-α and IL-6 were accompanied with increases in RANKL and NTX levels. Interestingly, 
BAP was also found to increase 5-minutes post-exercise, and continued to increase up to 24-
hours post-exercise. This finding was not expected however it may be due to mechanical strain or 
possibly direct effects of IL-6 on osteoblast precursor cells. OPG was found to increase 5-minutes 
post-exercise before declining 24-hours after exercise. This decline was associated with a 
decrease in IL-10. 
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mode of low-impact exercise. Contrary to high-impact exercise, cycling has been 
associated with poor outcomes on BMD due to the lack of mechanical loading. In fact, 
cyclists appear to have lower lumbar spine and hip BMD when compared to age-matched 
controls (Guillemant et al., 2004). However, BMD does not capture the short-term effects 
of exercise, thus these reports are not based on the acute effects of cycling. Therefore the 
use of biochemical markers of bone formation and resorption provides a dynamic and 
sensitive measure to assess the short-term effects of exercise on bone as seen with this 
study (Maimoun & Sultan, 2011). 
This study is the first of its kind to assess the acute effects of cycling on bone 
formation markers BAP and OPG and bone resorption markers NTX and RANKL. 
Comparing to baseline values, all markers exhibited a significant time effect in 
association to exercise (Figures 8-11). Although there are no reference reports for OPG, 
NTX, and RANKL, other markers of bone formation and resorption have also been 
reported to increase immediately and shortly after low-impact exercise such as CTX, OC, 
PICP, PIIIP, and ICTP (Guillemant et al., 2004; Herrmann et al., 2007; Maimoun et al., 
2006; Wallace et al., 2000).  
In this study, OPG and RANKL increased significantly 5 minutes post-exercise, 
indicating increased osteoblast responsiveness. According to in vitro studies that utilize 
osteoblast-osteoclast co-culture systems (Steeve et al., 2004), RANKL and OPG are 
secreted by osteoblasts and their precursors and are responsible for primarily regulating 
the activities of osteoclasts (Datta et al., 2008; Steeve et al., 2004). Based on the pro-
inflammatory cytokine response reported above, it is possible that increases in IL-1, 
TNF-α and IL-6 are associated with increased osteoclast differentiation by promoting the 
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production of RANKL and OPG, with a net increase in RANKL (Steeve et al., 2004). 
However other factors such as hormonal perturbations and mechanical strain may also be 
involved (Bergnan, 2013). 
Bone formation marker BAP also increased 5-minutes post-exercise. A similar 
finding was also reported by Rudberg et al. (1999), who found BAP increased 
significantly in postmenopausal women immediately after cycling. This effect may be 
due to the mechanical strain on bone that is associated with cycling (Tanaka et al., 2006; 
Rudberg et al., 1999).  With respect to in vitro studies, the application of shear stress 
results in increased mineralization and increased mRNA expression of osteocytes 
(Bloomfield, 2001; Owan et al., 1997). Similarly, increased blood flow induced by 
cycling can translate into shear stress on bone, which may increase bone formation 
(Tanaka et al., 2006). This may explain why BAP increased shortly after exercise. 
Furthermore, BAP remained elevated 1 hour and 24 hour post-exercise, which is in 
contradiction with other studies that showed a decline or no change in BAP following 
low-impact exercise (Banfi et al., 2010; Guillemant et al., 2004; Rudberg et al., 1999). As 
per Table 2, the only study in which BAP was shown to increase 24 hours post-exercise 
was by Tosun et al. (2006), who tested brisk walking and weight lifting on bone markers 
in young women. It was shown that brisk walking alone did not alter BAP levels, 
however brisk walking accompanied with weight lifting (5kg) lead to an increase in BAP 
levels 24-hours post-exercise (Tosun et al., 2006). From these findings it can be 
suggested that the mechanical strain or resistance accompanied with cycling may cause 
anabolic effects on bone that can be observed hours after the exercise (Tosun et al., 
2006).  
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The only marker that was found to be significantly lower 24 hours post-exercise 
was the bone resorption marker NTX. This finding is in accordance with the literature as 
bone resorption markers have generally been reported to decrease a couple of hours after 
exercise (Herrmann et al., 2007). Taken together with the current findings and 
particularly the increase in RANKL levels, it appears that primary acute effects of HIE on 
bone are linked to increased bone resorption. 
Given that HIE initially lead to increased bone resorption, followed by increased 
bone formation, these findings show that this form of exercise stimulates bone turnover. 
The process of bone turnover is very critical as it not only stimulates both osteoblast and 
osteoclast activity, but also presents a sign of continuous bone repair and regeneration of 
bone. The fact that a net bone accrual was not observed in this study (as indicated by 
bone markers) does not necessarily indicate that cycling or HIE has no benefits to bone. 
Rather, it further supports the hypothesis that in addition to bone quantity, the quality of 
bone (ie. the structure of bone) is also an important factor to determine bone strength 
(Gomez-Bruton et al. 2013). Thus, increased bone turnover in response to low impact 
exercise may indicate an improved structural adaptation of bone that results in increased 
overall bone strength.  
The main focus of this study was to evaluate the association between cytokines 
and bone turnover markers. Significant correlations were found between the percent 
changes of certain markers at the same time points as presented in Figures 17-20. At 5-
minutes, it was observed that an increase in BAP levels was negatively correlated with a 
decline in IL-10 levels. Based on the sequence of cytokine release after exercise, it is 
expected that BAP levels would be higher prior to production of IL-10. According to in 
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vitro studies, the incubation of osteoblast precursors with IL-10 leads to a suppression in 
differentiation and mineralization (Lee et al., 2008). Indeed, the incubation of 
preosteoblast cultures with IL-10 inhibits BAP expression in preosteoblast cultures 
(Garcia-Lopez et al., 2005). Based on this association, it is expected that higher levels of 
BAP will be associated with lower circulating levels of IL-10. Thus it is possible that the 
effects of shear stress (mechanical strain) on osteoblasts and their precursors cells 
coupled by low levels of circulating IL-10 attribute for the rapid increase in BAP.   
At 24 hours, an increase in BAP levels was negatively correlated with a decline in 
levels of IL-1α. Although IL-1α inhibits osteoblast proliferation, it has only been 
reported to have stimulatory effects on bone formation and BAP expression in both in 
vitro and animal research (Hughes et al., 2000; Lee et al., 2010). Based on these studies, 
it is predicted that a decline in IL-1α would be associated with a decline in BAP; 
however this was not the case. Therefore this further supports the postulation that perhaps 
the increase in BAP was due to other factors such as mechanical strain that induces 
anabolic effects on bone (Tosun et al., 2006). 
Furthermore, at 24-hours we observed a positive correlation between OPG and 
IL-10. Both OPG and IL-10 decline in comparison to their 5-minute and 1-hour values, 
which is expected based on Figure 7. IL-10 has been demonstrated by a few studies to 
reduce bone resorption by downregulating RANKL and by enhancing OPG production 
(Lee et al., 2008; Hong et al., 2000; Liu et al., 2006). According to animal studies, IL-10 
knockout mice present increased bone resorption, and decreased OPG gene expression 
(Liu et al., 2006). More studies are needed to assess the effects of IL-10 on OPG 
expression, however our findings may indicate that IL-10 levels may influence OPG 
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secretion by osteoblasts in combination with the decline in pro-inflammatory cytokines 
observed 24-hours post-exercise.  
A positive correlation was also observed between NTX and TNF-α 24-hours post-
exercise. As levels of NTX declined, so did levels of TNF-α, indicating that this cytokine 
may possibly contribute to the bone resorptive effect of exercise along with other factors 
such as hormonal perturbations and mechanical strain. The effects of TNF-α on bone 
resorption have been investigated previously with pharmaceuticals that regulate the 
activity of this cytokine (Charatcheroenwitthaya et al., 2007). In fact, a similar positive 
correlation with NTX and TNF-α was observed in a previous study that tested the effects 
of infliximab, an antagonist of TNF-α, in patients with arthritis (Korczowska et al., 2013).  
Short-term administration of infliximab lead to a reduction in both serum NTX and TNF-
α, both of which were also found to be significantly correlated with each other in that 
study. A study that used a different TNF-α blocker known as etanercept, also found that 
short-term administration of this pharmaceutical lead to a decline in NTX levels 
(Charatcheroenwitthaya et al., 2007). In addition, Korczowska et al. (2013) found that the 
lower NTX levels were positively correlated with lower levels of the TNF-α receptor 1 
(TNF-R1). TNF-R1 also increases immediately after exercise to counterbalance the 
increased renal clearance of TNF-α, and declines a few hours later (Katsuhiko, 2002). 
Although TNF-R1 was not measured in this study, it may have also declined. The decline 
in both TNF-α and possibly TNF-R1 would result in less TNF-α binding on to thereby 
reducing bone resorption and ultimately NTX production. 
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5.2 Conclusion 
It was shown that low-impact HIE induces a combined bone turnover and cytokine 
response. As evidenced by the changes in RANKL and NTX, this type of exercise was 
mostly associated with a bone resorptive effect, which declined 24-hours post-exercise. It 
was also found that cycling may be associated with increased bone formation through 
increased BAP production, however the mechanism by which this occurs remains to be 
elucidated. In accordance to previous literature as well as Figure 6, the exercise used 
initially stimulated a pro-inflammatory cytokine response followed by an anti-
inflammatory cytokine response. Most importantly, this study found that significant 
correlations existed between bone turnover markers and certain cytokines as 
hypothesized in Figure 7. Although one correlation needs further investigation, the 
correlations between BAP, OPG and NTX with IL-1α, IL-10, and TNF-α respectively 
indicate that cytokines may interact with bone to induce exercise changes on bone 
formation and bone resorption. Most of the explanations of the effects of the cytokines on 
bone were based on in vitro and in vivo studies and not exercise trials, however it is 
possible that the way in which cytokines and bone interacted during exercise is similar to 
the interactions in these previous studies. Nonetheless, more research is required to 
further elucidate the mechanisms in which cytokines regulate bone formation and bone 
resorption during exercise. 
 Assessing the mechanisms by which cytokines and bone interact during exercise 
would provide the most reliable evidence of the interdependence of both systems. 
Although it was not possible to depict mechanisms in this study, the correlations provide 
the first step into doing so, The correlations observed between the pro- and anti-
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inflammatory cytokine response and bone turnover markers predict an interdependence 
found between the skeletal and immune systems. Further investigation is required to 
determine whether the correlations between cytokines and bone depict a cause-effect 
relationship, or whether they present cytokines as additional factors that promote bone 
turnover during exercise. Indeed, these systems are not separate entities and their 
interaction may be responsible for beneficial effects of exercise on bone health and 
inflammatory status. 
 
5.3 Limitations and Future Considerations 
Although bone turnover and cytokine responses were detected after exercise, a few 
limitations are associated with this study. While exercise stimulates the increase of 
several metabolic factors such as hormones and cytokines, it is also associated with 
hemoconcentration and plasma volume expansion. This is explained by the redistribution 
of blood flow to across extracellular and interstitial compartments. This may cause 
fluctuations in concentrations (Brahm et al., 1997), thereby providing misleading results.  
Thus, calculating the plasma volume in this study may have been beneficial to support 
whether the results were indeed reflections of the exercise. However, Brahm et al. (1997) 
have found that plasma volume does not significantly change osteocalcin levels nor alter 
this bone marker response. It is possible, therefore, that the plasma volume effect in this 
study was not significant.  
 The second limitation of this study was the lack of assessing receptors and 
receptor antagonists alongside with the other parameters. Although we were able to 
observe variations in cytokines after exercise, we cannot fully determine the 
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inflammatory response given that the effect of these cytokines depends on receptor 
binding. For future consideration, it would be advantageous to also assess the levels 
receptors of these cytokines as well as their receptor antagonists.  
 Another limitation of this study was the sample size. Although the sample size 
was sufficient for the bone marker analysis, the missing data led to a small sample for the 
cytokine analysis. This was handled using non-parametric statistics for the analysis and 
significant effects were found for most but not all cytokines.  
 Finally, the use of nutritional assessments could have been beneficial in this 
study. Nutrition is an important exogenous factor that may influence both bone health and 
cytokine dynamics. Both glucose, glycogen and protein have been reported to influence 
bone markers and cytokines during and after exercise (Chan et al., 2004; Kerasioti et al., 
2013).  
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Appendix B 
 
INVITATION LETTER 
The systemic effects of acute exercise on osteoblasts in vitro 
Principal Investigators: Dr. Nota Klentrou and Yasmeen Mezil, Faculty of Applied 
Health Sciences. 
 
We would like to invite you to participate in the present study, which investigates the 
effects of acute exercise on osteoblasts (bone cells) in adult males using an 
interdisciplinary approach which involves applied physiology and cell culture techniques. 
 
The purpose of this research project is to examine the growth and maturation of 
osteoblasts, as measured with a cell culture system, in response to one acute exercise 
session in moderately to regularly physically active adult males. In other words, we 
would like to determine the cellular mechanisms of which acute exercise enhances bone 
status.  
 
This study requires three short visits to the Applied Physiology Lab (30 minutes, 2 hours, 
15 minutes). During these visits, participants will fill out two questionnaires on medical 
history and physical activity and will also perform an exercise protocol on a cycle 
ergometer for approximately 15 minutes. The exercise will include short warm-up and 
cool-down intervals. Blood sampling will be conducted as the physiological assessment 
for this study. Blood samples will be collected from participants prior to exercise and 5 
minutes, 1 hour, and 24 hours after exercise. 
 
Participation in this project will allow the opportunity to experience a research facility at 
Brock and contribute to the advancement of science. 
This research is being performed only by Brock University researchers in the 
Applied Physiology Laboratory and Cairns Family Health and Bioscience Research 
Complex. 
If you have any pertinent questions about your rights as a research participant, please 
contact the Brock University Research Ethics Officer (905 688-5550 ext 3035, 
reb@brocku.ca) 
 
If you have any questions, please feel free to contact us. 
 
Thank you, 
 
Principal Investigators:   
Dr. Nota Klentrou and Yasmeen Mezil  
Faculty of Applied Health Sciences 
Brock University 
Tel: 905-688-5550 ext: 4538 or 5623 
 email: nklentrou@brocku.ca or ym07tv@brocku.ca  
This study has been reviewed and received ethics clearance through Brock University’s Research Ethics 
Board  [12-012 KLENTROU] 
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Appendix D 
 
RESEARCH STUDY INFORMATION AND CONSENT 
 
The systemic effects of acute exercise on osteoblasts in vitro 
 
You are being invited to participate in a research study being conducted by the 
investigators listed below. Prior to participating in this study, please read this form to find 
out about the purpose and the tests of this study. This study is sponsored by the Faculty of 
Applied Health Sciences of Brock University. 
 
INVESTIGATORS:   DEPARTMENT:             CONTACT: 
Dr. Nota Klentrou   FAHS, Brock University      (905) 688-5550  x4538 
Yasmeen Mezil   FAHS, Brock University      (905) 688-5550 x5623 
* FAHS = Faculty of Applied Health Sciences 
 
PURPOSE: 
The primary objective of this study is to utilize cell culture tools to investigate the 
systemic effects of exercise on osteoblasts in vitro. The specific objectives of the study 
are: a) to examine osteoblast proliferation and differentiation upon inducing the cells with 
post-exercise serum samples, b) to examine bone nodule mineralization as a response to 
continual incubation of the osteoblasts with post-exercise serum, and c) to investigate the 
expression of anabolic proteins by osteoblasts as response to serum incubation. 
 
DESCRIPTION OF THE TESTING PROCEDURES: 
 
A. Pre and Post Assessments at Brock University:  
All participants enrolled in this study will be asked to visit the Applied Physiology at 
Brock University for three appointments. In the first appointment, the researcher will sit 
with the participant to go through the study protocol and to determine the maximum 
workload he can perform on the ergometer. In addition, the participant will also fill out 
all necessary questionnaires of the study. In the second appointment, participants will 
provide a blood sample, and perform the exercise intervention component. On the third 
appointment (which is on the consecutive day after the appointment) participants will 
return to have final blood samples collected. The measurements that will be completed by 
the participants during these visits as well as throughout the cell culture component are 
listed below: 
 
Measurements: 
 
1. Participant Screening and Medical History Questionnaire: Every participant will 
be required to complete this questionnaire before completing any other measure. 
This questionnaire allows us to have a better understanding of the participant’s 
medical background in order to interpret data properly and to make sure that they 
are able to participate in all of the required measurements.  
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2. Physical Activity Questionnaire for Adults: This is a brief questionnaire that asks 
participants to recall their physical activity level in the past week. 
3. Pre-exercise Blood Collection: 10 mL of blood will be withdrawn from the 
participants by a certified researcher from each participant prior to exercise. 
Blood will be collected using a 22G safety needle from the median cubital vein. 
4. Post-exercise Blood Collection: Blood samples will also be collected 5 min, 1 hr, 
and 24 hr after the acute exercise intervention (10 mL per draw). Blood will be 
withdrawn from the participants by a certified phlebotomist. The blood will be 
collected using a 22G safety needle from the median cubital vein (Total amount of 
blood drawn for pre-exercise and post-exercise will be 40 mL from each 
participant, 10 mL per draw). 
5. Serum: The blood samples will be allowed to clot overnight at 4ºC, following a 
centrifugation at 400 x g. The serum layer will be removed and separated into 2 
mL aliquots prior to being frozen at -80ºC for later studies.  
6. Enzyme-linked Immunosorbent Assay: 200 µL of Wash Buffer will be added into 
each well of a Microtiter Filter Plate. The plate will be sealed and placed on a 
plate shaker for 10 minutes at room temperature (20-25°C). The buffer will be 
removed and 25 µL of each Standard will be subsequently added in the 
appropriate wells, following the addition of 25 µL of Assay Buffer to the sample 
wells and 25 µL of appropriate matrix solution to the background, standards, and 
control wells.  25 µL of the serum samples will be added into the appropriate 
wells. 25 µL of the premixed beads will be added to each well. The plate will be 
sealed and incubated with agitation overnight at 4°C. After the media is removed, 
the plate will be washed 2 times with 200 µL/well of Wash Buffer. 25 µL of 
Detection Antibodies will be added into each well and the plate will be incubated 
with agitation on a plate shaker for 1 hour at room temperature. 25 µL of 
Streptavidin-Phycoerythrin will be added to each well containing the 25 µL of 
Detection Antibodies. Similarly the plate will be sealed and incubated with 
agitation on a plate shaker for 30 minutes at room temperature. All of the contents 
will be subsequently removed by vacuum and 150 µL of Sheath Fluid will be 
added to all wells. The plate will be run on a Luminex 100™ and fluorescence 
will be analyzed. 
7. Serum Dilutions: For each outcome measure assessed in osteoblasts, the serum 
treatments will be diluted in a growth media to form 10% human serum solution.  
8. Osteoblast Incubation: Adult human osteoblasts (hOB) will be treated with 10% 
fetal bovine serum (FBS), 1mM L-gluatmine and 100 ng/ml gentamicin at 37ºC in 
a humidified atmosphere containing 5% CO2. Cells will be passaged when near 
confluent monolayers are achieved. The cells will be seeded into 96-well plates 
for the cell proliferation and differentiation assays, and in 10 cm plates for the 
proteomic analysis. The FBS media will be replaced with 10% human serum to 
investigate osteoblast proliferation, differentiation, bone nodule mineralization, 
and proteomic analysis. 
9. Osteoblast Proliferation: Osteoblast proliferation will be assessed using a 
thymidine assay, which measures DNA synthesis, and a crystal violet assay, 
which measures the number of cells present. Following the incubation of 
osteoblasts in 24-well plates, the cells will be pulse-labeled with 10 µCi/well of 
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[3H]-thymidine. Cells will then be lysed with 1.5% sodium dodecyl sulfate for 15 
min, after which they will be combined with scintillation fluid and the 
radioactivity will be measured using a liquid scintillation counter. In addition, 
osteoblasts will also be treated with crystal violet stain solution in 96-well plates. 
The plate will then be allowed to dry overnight or for a couple of hours.  Once the 
plate is dry, 100 μL of sodium phosphate solution (0.05 M NaH2PO4 in 50% 
ethanol) will be added to each well. The plate will be gently shaken for 30 
minutes and subsequently read at an absorbance of 570 nm after 1 second of low 
agitation. The relative spectrophotometry readings will be directly proportional to 
cell numbers. 
10. Osteoblast Differentiation: Alkaline phosphatase (ALP) is an enzyme that is 
activated during osteoblast differentiation. Osteoblasts will be seeded in 10 cm 
plates and will be incubated for 3-4 days. The treatment medium will be added for 
a length of 15 min and subsequently the cells will be lysed. The cell lysate 
containing 2 µg total protein will be added to the assay buffer (2 mM p-
nitrophenol phosphate, 1 mM MgCl2, 50 mM Tris-HCl/pH 9.2). After 10 min 
incubation at 37ºC, the reaction will be terminated by the addition of NaOH. The 
absorbance of p-nitrophenol liberated in the reactive solution will be read at 420 
nm. The relative ALP activity was defined as nonmoles of p-nitrophenol 
phosphate hydrolyzed per minute per 1 µg of total protein.  
11. Bone Nodule Mineralization: Osteoblasts will be grown in 10% FBS media on 
24-well plates. For 35 days, this medium will be fortified with β-
glycerophosphate (10 mM) and ascorbic acid (50 µg/ml). At each assay interval 
(every 7 days), the cells will be rinsed three times with PBS and fixed with 95% 
methanol for 30 min. Subsequently, the cells will be stained with 1% alizarin red 
S at pH 6.4 for 5 min and washed with distilled water. Water will be removed 
aspiration, and the cells will be incubated in PBS for 15 min at room temperature 
on an orbital rotator. The PBS will be removed, and the cells will be rinsed once 
with fresh PBS. The counting of mineralized alizarin red S-positive nodules 
present in each well will be performed using light microscopy. 
12. Proteomic Analysis: Osteoblasts will be seeded in 10 cm plates and will be 
incubated for 3-4 days. 10% human serum will be added for a length of 15 min 
and subsequently the cells will be lysed. The protein content of the osetoblasts 
will be assessed using the BioRad assay. A 3x electrophoresis sample buffer will 
be used to solubilize the lysates. After the addition of the electrophoresis sample 
buffer the samples will be boiled for 5 min and stored at -20ºC. Protein samples 
will be loaded into wells of a 10% SDS-polyacrylamide gel and separated by 
electrophoresis at 120V for approximately 2 hours. The samples will subsequently 
be transferred from gel to a PVDF membrane at 100V for 1 hour. After transfer, 
the membrane will be washed for 5 min with 25 ml 1xTBS followed by 
incubation for 1 hour at room temperature in an agitator with 10 ml of 5% (w/v) 
non-fat dry milk in Tris-buffered saline. Afterwards the membranes will be rinsed 
with 25 ml of TBS/T and then overnight at 4ºC with the primary antibody diluted 
(1:1000) in primary antibody dilution buffer with gentle agitation. The following 
primary polyclonal antibodies will be used: Phospho-catenin, Total-catenin,Total 
RANKL, Phospho-Akt, Total-Akt, Phospho-AMPK, and Total-AMPK. The next 
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day the membranes will be washed 3x for 5 min with 15 min with 15 ml TBS/T, 
and the primary antibody will be detected with HRP-conjugated secondary 
antibody diluted in blocking buffer (1:2000) which will be incubated with the 
membrane for at least an hour at room temperature. This will be followed by 
washing the membranes 3x for 5 minutes with TBS/T and the secondary antibody 
will be detected by ChemiGlo reagent and visualized by FluroChem software via 
an autodeveloper (ThermoFisher). 
 
B. Acute Exercise Intervention Session: 
Participants will be prescribed a high-interval training (HIT) session as prescribed by 
Gibala & McGee (2007). In this session participants will perform a high-intensity interval 
training (HIT) program which will involve six 1-minute intervals of all-out maximal 
cycling against a high braking force on a specialized ergometer, which will be separated 
by 1-minute recovery periods. Thus the total time for the HIT program should 
approximately be 15 minutes, including warm-up. The session will take place in the 
Applied Physiology Lab on a cycle ergometer. The HIT session will  
only be performed once, in which blood samples will be collected prior to the session and 
5 min, 1 hr, and 24 hr after the session. 
 
 
CONFIDENTIALITY: 
All data collected during this study will remain confidential and will be stored in offices 
and on secured computers to which only the principal and co-investigators have access. 
You should be aware that the results of this study will be made available to scientists, 
through publication in a scientific journal, but your name and any personal data will not 
appear in compiling or publishing these results. Data will be kept for 5 years after the 
date of publication, at which time all information will be destroyed.  Additionally, you 
will have access to your own data, as well as the group data when it becomes available 
and if you are interested. 
 
PARTICIPATION & WITHDRAWAL: 
You may choose whether to participate in this study or not and may remove your data 
from the study if you wish. You may also refuse to answer any questions posed during 
the study and still remain as a participant in the study. The investigators reserve the right 
to withdraw you from the study if they believe that it is necessary. 
 
RISKS AND BENEFITS: 
The only foreseeable risks involved in participation include: 
a) Possible muscle soreness and fatigue within 48 h of the exercise session. If this 
occurs, it will only be temporary.  
b) The exercise test may cause dizziness, nausea, or fainting. The principle 
investigators will monitor you during the exercise to make sure that this does not 
happen and to assist you if you feel any discomfort. In addition, you will be asked 
to make sure you have consumed enough fluids and a good, rich in carbohydrates 
meal and fluids approximately 2 hours prior to your arrival at the laboratory.  
c) Blood collection may pose the risk of fainting or the development of an infection. 
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This risk however will be minimized by professional venipuncture practice. 
d) Some questionnaires may pose a potential embarrassment. In such a case, you do 
not need to reply to any question if you do not wish to. 
 
The significance of the proposed research will benefit the scientific and clinical 
communities by advancing the understanding of the mechanisms induced by exercise 
which are responsible for enhancing overall health and bone health. It will also allow the 
researchers to elucidate the systemic factors of which exercise improves bone strength 
and function. Your participation will allow you to contribute to the advancement of 
science, become exposed to a research protocol, and gain knowledge about the function 
of your own body. 
 
RIGHTS OF RESEARCH PARTICIPANTS: 
You will receive a signed copy of this consent form. You may withdraw your consent to 
participate in this study at any time, and you may also discontinue participation at any 
time without penalty. In signing this consent form or in participating in this study you are 
not waiving any legal claims or remedies. This study has been reviewed and received 
clearance from the Brock University Research Ethics Board (12-012 KLENTROU) If you 
have any pertinent questions about your rights as a research participant, please contact the 
Brock University Research Ethics Officer (905 688-5550 ext 3035, reb@brocku.ca) 
 
 
INFORMATION: 
 
Please contact Yasmeen Mezil at 905-688-5550 (X5623 or X6112) or Dr. Nota Klentrou 
at 905-688-5550 (X4538), if you have any questions about the study. 
 
I HAVE READ AND UNDERSTAND THE ABOVE EXPLANATION OF THE 
PURPOSE AND PROCEDURES OF THE PROJECT. I HAVE ALSO RECEIVED 
A SIGNED COPY OF THE INFORMATION AND CONSENT FORM. MY 
QUESTIONS HAVE BEEN ANSWERED TO MY SATISFACTION AND I 
AGREE TO PARTICIPATE IN THIS STUDY.  
 
I UNDERSTAND THAT I HAVE TO EAT A GOOD MEAL RICH IN 
CARBOHYDRATES AND FLUIDS APPROXIMATELY 2 HOURS PRIOR TO 
MY ARRIVAL TO THE LABORATORY AND THAT I WILL NEED TO WEAR 
COMFORTABLE ATTIRE SUITABLE FOR EXERCISING. 
 
 
 
            
SIGNATURE of PARTICIPANT                DATE 
 
 
            
PRINTED NAME OF PARTICIPANT   DATE 
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WITNESS      DATE 
 
 
      
PRINTED NAME OF WITNESS 
 
 
 
 
INVESTIGATOR 
 
In my judgment the participant is voluntarily and knowingly giving informed consent and 
possesses the legal capacity to give informed consent and participate in this research 
study. 
 
 
            
SIGNATURE OF INVESTIGATOR   DATE 
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Appendix E 
 
SUBJECT SCREENING AND MEDICAL HISTORY QUESTIONNAIRE 
 
 
Name: ___________________________________________         Date: _______________  
 
Date of Birth: __________________________________ 
 
 
Your responses to this questionnaire are confidential.  If you answer “YES” to any of 
the following questions, please give additional details in the space provided and 
discuss the matter with one of the investigators.  You may refuse to answer any of 
the following questions. 
 
 
1. Have you ever had any major joint instability or ongoing chronic 
pain such as in the knee, back or elbow? 
 
YES NO 
2. Are you currently taking any medication (including aspirin) or 
have you taken any medication in the last two days? 
 
YES NO 
3. Have you taken any medication in the past six months? 
 
YES NO 
4. Is there any medical condition with which you have been 
diagnosed and are under the care of a physician (e.g. asthma, 
diabetes, anorexia)? 
 
YES NO 
5. Do you, or have you in the past, consumed any alcohol on a 
regular basis? 
 
YES NO 
6. Do you, or have you in the past, smoked on a regular basis? 
 
YES NO 
7. Are you, or have you in the past, engaged in any extreme diet? 
 
YES NO 
8. Do you, or have you in the past, consumed any nutritional 
supplements (e.g. calcium, multi-vitamin) on a regular basis? 
 
YES NO 
9. Do you, or have you in the past, engaged in physical activity on a 
regular basis? 
 
YES NO 
10. Have you had any fractures? 
 
YES NO 
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Appendix F 
 
 
GODIN-SHEPHARD LEISURE-TIME EXERCISE QUESTIONNAIRE 
 
 
Name: ________________________   Date: ____________ 
 
 
1. Considering a 7-day period (a week), how many times on the average do you do 
the following kinds of exercise for more than 15 minutes during your free-
time (write on each line the appropriate number)? 
  
          Times Per Week 
 
(a) STRENUOUS EXERCISE 
(HEART BEATS RAPIDLY)                             _________ 
(i.e. running, jogging, hockey, football, soccer, squash, basketball,  
cross country skiing, judo, roller skating, vigorous swimming,  
vigorous long distance bicycling) 
 
(b) MODERATE EXERCISE       
 (NOT EXHAUSTING)      _________ 
(i.e. fast walking, baseball, tennis, easy bicycling, volleyball,  
badminton, easy swimming, alpine skiing, popular and folk dancing) 
 
(c) MILD EXERCISE 
 (MINIMAL EFFORT)     _________ 
 (i.e. yoga, archery, fishing from river bank, bowling, horseshoes,  
golf, snow-mobiling, easy walking) 
 
 
2. Considering a 7-day period (a week), during your leisure-time, how often do 
you engage in any regular activity long enough to work up a sweat (heart beats 
rapidly)?  
 
1. OFTEN     2. SOMETIMES  3. NEVER/RARELY 
            
 
